# CBD Portal - Master Plan v6

**Target:** European CBD market leadership through independent, research-backed education  
**Structure:** Independently owned by expert author team  
**Primary Markets:** International English â†’ Danish â†’ German  
**Last Updated:** January 10, 2026

**v6 Updates:** Added Wave Publishing Model, Content Depth Framework, Unified Backend Architecture, Translation System, Comment System, Database Schema

---

## EXECUTIVE SUMMARY

CBD Portal is an independently owned CBD information platform designed to educate consumers through objective, research-backed content. By maintaining complete editorial independence and a rigorous benchmark system, the platform allows quality brands to demonstrate their superiority through transparent evaluation rather than marketing claims.

**Core Principles:**
- 100% editorially independent
- No affiliate relationships
- Objective benchmark scoring
- Research-backed content (698 studies)
- Consumer education first

---

## TABLE OF CONTENTS

### Part 1: Strategic Foundation
1. [Ownership & Independence](#1-ownership--independence)
2. [Revenue Model](#2-revenue-model)
3. [Domain Portfolio](#3-domain-portfolio)
4. [Multi-Site Architecture](#4-multi-site-architecture)

### Part 2: Content Production Strategy
5. [Content Overview](#5-content-overview)
6. [Wave Publishing Model](#6-wave-publishing-model)
7. [Content Depth Framework](#7-content-depth-framework)
8. [Keyword Validation Process](#8-keyword-validation-process)
9. [Content Production Pipeline](#9-content-production-pipeline)
10. [Three-Market Launch Plan](#10-three-market-launch-plan)
11. [Complete Article List](#11-complete-article-list)
12. [Research Integration](#12-research-integration)

### Part 3: Brand Benchmark System
13. [Benchmark Scoring Methodology](#13-benchmark-scoring-methodology)
14. [Brand Review Process](#14-brand-review-process)

### Part 4: Newsletter Strategy
15. [Newsletter Architecture](#15-newsletter-architecture)
16. [Lead Magnets & Growth](#16-lead-magnets--growth)

### Part 5: Writing & Production
17. [Brand Voice & Tone](#17-brand-voice--tone)
18. [Article Templates](#18-article-templates)
19. [SEO Requirements](#19-seo-requirements)
20. [Quality Checklist](#20-quality-checklist)

### Part 6: Technical Architecture
21. [Unified Backend System](#21-unified-backend-system)
22. [Database Schema](#22-database-schema)
23. [Translation System](#23-translation-system)
24. [Comment System](#24-comment-system)
25. [Tools Strategy](#25-tools-strategy)
26. [Internal Linking](#26-internal-linking)

### Part 7: Launch & Operations
27. [Launch Criteria & Phases](#27-launch-criteria--phases)
28. [Publication Timeline](#28-publication-timeline)
29. [Success Metrics](#29-success-metrics)

### Appendices
- [Appendix A: E-E-A-T Strategy](#appendix-a-e-e-a-t-strategy)
- [Appendix B: Localization Guidelines](#appendix-b-localization-guidelines)
- [Appendix C: Legal & Compliance](#appendix-c-legal--compliance)
- [Appendix D: Future Markets](#appendix-d-future-markets)

---

# PART 1: STRATEGIC FOUNDATION

---

## 1. OWNERSHIP & INDEPENDENCE

### 1.1 Ownership Structure

CBD Portal is independently owned and operated by a team of expert authors. It is **not** owned by any CBD brand, manufacturer, or retailer.

```
CBD PORTAL (Independent Entity)
â”œâ”€â”€ Owned by: Expert Author Team
â”œâ”€â”€ Editorial: 100% independent
â”œâ”€â”€ Revenue: Newsletter sponsorships, advertising
â”œâ”€â”€ Reviews: Objective benchmarking only
â”‚
â””â”€â”€ All brands reviewed equally
    (Quality brands will stand out on merit)
```

### 1.2 Expert Author Team

| Role | Credentials Required | Responsibilities |
|------|---------------------|------------------|
| **Editor-in-Chief** | Journalism/health writing background | Editorial standards, final approval |
| **Medical Reviewer** | MD, PharmD, PhD, or RN | Reviews health claims, condition articles |
| **Science Advisor** | Research background in cannabis/pharmacology | Research interpretation, study database |
| **Industry Expert** | 5+ years CBD/cannabis industry | Brand evaluation, product knowledge |

**Requirements for all team members:**
- Real people with verifiable credentials
- Publicly named with photos and bios
- LinkedIn profiles or professional presence
- No undisclosed conflicts of interest

### 1.3 Independence Statement

```
OUR INDEPENDENCE PROMISE

CBD Portal is independently owned by our editorial team.
We are not owned by any CBD brand or manufacturer.

We do not participate in affiliate programs.
We earn nothing when you click a link or buy a product.

Our reviews are based solely on our published methodology.
No brand can pay for a better score.

We are funded by newsletter sponsorships and display advertising,
which are always clearly separated from editorial content.

This is why you can trust our recommendations.
```

### 1.4 Conflict of Interest Policy

- All potential conflicts must be disclosed
- Team members cannot own stock in reviewed brands
- Sponsored content is always clearly labeled
- Advertising never influences editorial content
- Brand disputes are handled through published appeals process

---

## 2. REVENUE MODEL

### 2.1 Revenue Streams

| Revenue Stream | Description | % of Revenue (Target) |
|----------------|-------------|----------------------|
| **Newsletter Sponsorships** | Brands sponsor newsletter editions | 50-60% |
| **Display Advertising** | Programmatic ads (Mediavine/AdThrive) | 30-40% |
| **Sponsored Content** | Clearly labeled brand articles | 5-10% |
| **Premium Reports** | Industry analysis, market reports | 5% |

### 2.2 What We Don't Do

| âŒ Not Accepted | Reason |
|----------------|--------|
| Affiliate links | Creates bias toward brands with programs |
| Pay-for-review | Undermines trust |
| Pay-for-score | Destroys credibility |
| Hidden sponsorships | Illegal in most jurisdictions |
| Exclusive brand deals | Limits objectivity |

### 2.3 Advertising Guidelines

**Acceptable:**
- Display ads in designated areas
- Sponsored newsletter sections (labeled)
- Sponsored content (clearly marked)
- Brand directory enhanced listings (features, not scores)

**Never Acceptable:**
- Ads that mimic editorial content
- Popup ads over content
- Ads for unreviewed products claiming endorsement
- Any advertising that influences review scores

---

## 3. DOMAIN PORTFOLIO

### 3.1 Premium Exact-Match Domains (ccTLDs)

| Domain | Market | Language | Population | Est. CBD Market |
|--------|--------|----------|------------|-----------------|
| **CBD.de** | Germany | German | 83M | â‚¬1.8B |
| **CBD.it** | Italy | Italian | 60M | â‚¬400M |
| **CBD.se** | Sweden | Swedish | 10.5M | â‚¬150M |
| **CBD.no** | Norway | Norwegian | 5.4M | â‚¬100M |
| **CBD.dk** | Denmark | Danish | 5.8M | â‚¬80M |
| **CBD.fi** | Finland | Finnish | 5.5M | â‚¬70M |
| **CBD.pt** | Portugal | Portuguese | 10.3M | â‚¬60M |

### 3.2 Branded Portal Domains

| Domain | Market | Language | Population | Est. CBD Market |
|--------|--------|----------|------------|-----------------|
| **cbdportal.es** | Spain | Spanish | 47M | â‚¬350M |
| **cbdportal.ch** | Switzerland | German/French | 8.7M | â‚¬200M |
| **cbdportail.fr** | France | French | 67M | â‚¬500M |
| **cbdportaal.nl** | Netherlands | Dutch | 17.5M | â‚¬250M |
| **cbdportal.ro** | Romania | Romanian | 19M | â‚¬50M |
| **swissorganic.co.uk** | UK | English | 67M | â‚¬600M |

### 3.3 International Domain

| Domain | Status | Purpose |
|--------|--------|---------|
| **TBD** | To be acquired | International English foundation |

**Options under consideration:**
- cbdportal.com
- cbd-portal.com
- cbdportal.eu
- thecbdportal.com

### 3.4 Portfolio Summary

| Metric | Value |
|--------|-------|
| **Total Markets** | 13 |
| **Total Population Reach** | ~407M people |
| **Total Addressable Market** | ~â‚¬4.6B+ |
| **Premium ccTLDs Owned** | 7 |
| **Branded Portals Owned** | 6 |

---

## 4. MULTI-SITE ARCHITECTURE

### 4.1 Architecture Decision

**Selected: Option A â€” Separate Sites**

Each market operates as an independent site on its own domain, sharing a central database infrastructure.

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                    SHARED INFRASTRUCTURE                     â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”‚
â”‚  â”‚              SUPABASE DATABASE (Central)             â”‚   â”‚
â”‚  â”‚  â€¢ Research Studies (698) â€” all languages            â”‚   â”‚
â”‚  â”‚  â€¢ Glossary Terms (251) â€” translated per language    â”‚   â”‚
â”‚  â”‚  â€¢ Brand Data â€” core + market-specific               â”‚   â”‚
â”‚  â”‚  â€¢ Article Content â€” per language                    â”‚   â”‚
â”‚  â”‚  â€¢ Tools Data â€” shared logic                         â”‚   â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                              â”‚
        â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
        â–¼                     â–¼                     â–¼
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”    â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”    â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ INTERNATIONALâ”‚    â”‚    CBD.DK    â”‚    â”‚    CBD.DE    â”‚
â”‚   ENGLISH    â”‚    â”‚    DANISH    â”‚    â”‚    GERMAN    â”‚
â”‚              â”‚    â”‚              â”‚    â”‚              â”‚
â”‚  Foundation  â”‚    â”‚  + DK brands â”‚    â”‚  + DE brands â”‚
â”‚  850 articlesâ”‚    â”‚  + DK legal  â”‚    â”‚  + DE legal  â”‚
â”‚  100+ brands â”‚    â”‚  + DK news   â”‚    â”‚  + DE news   â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜    â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜    â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
     PHASE 1             PHASE 2             PHASE 3
```

### 4.2 Technical Specification

```
CODEBASE STRUCTURE (Monorepo)

/cbd-portal
â”œâ”€â”€ /apps
â”‚   â”œâ”€â”€ /international    â†’ [international-domain.com]
â”‚   â”œâ”€â”€ /denmark          â†’ cbd.dk
â”‚   â””â”€â”€ /germany          â†’ cbd.de
â”œâ”€â”€ /packages
â”‚   â”œâ”€â”€ /ui               â†’ Shared React components
â”‚   â”œâ”€â”€ /database         â†’ Supabase client & queries
â”‚   â”œâ”€â”€ /content          â†’ Content utilities
â”‚   â””â”€â”€ /i18n             â†’ Translation system
â”œâ”€â”€ /locales
â”‚   â”œâ”€â”€ /en               â†’ English translations
â”‚   â”œâ”€â”€ /da               â†’ Danish translations
â”‚   â””â”€â”€ /de               â†’ German translations
â””â”€â”€ /public
    â””â”€â”€ /shared           â†’ Shared assets
```

### 4.3 Database Schema (Multi-Language)

```sql
-- Articles table with multi-language support
CREATE TABLE articles (
  id UUID PRIMARY KEY,
  slug_en VARCHAR(255),
  slug_da VARCHAR(255),
  slug_de VARCHAR(255),
  title_en VARCHAR(255),
  title_da VARCHAR(255),
  title_de VARCHAR(255),
  content_en TEXT,
  content_da TEXT,
  content_de TEXT,
  category VARCHAR(100),
  status VARCHAR(50),
  published_at TIMESTAMP,
  updated_at TIMESTAMP
);

-- Research studies (shared, with translated metadata)
CREATE TABLE research_studies (
  id UUID PRIMARY KEY,
  title_en VARCHAR(500),
  title_da VARCHAR(500),
  title_de VARCHAR(500),
  abstract_en TEXT,
  abstract_da TEXT,
  abstract_de TEXT,
  -- Core data (not translated)
  authors TEXT[],
  journal VARCHAR(255),
  year INTEGER,
  doi VARCHAR(255),
  conditions TEXT[],
  sample_size INTEGER
);

-- Brands (international + market-specific)
CREATE TABLE brands (
  id UUID PRIMARY KEY,
  name VARCHAR(255),
  country_of_origin VARCHAR(100),
  markets_available TEXT[],  -- ['international', 'denmark', 'germany']
  website VARCHAR(255),
  scores JSONB,
  -- Market-specific flags
  is_danish_brand BOOLEAN DEFAULT FALSE,
  is_german_brand BOOLEAN DEFAULT FALSE
);
```

### 4.4 Content Sharing Model

| Content Type | Shared? | Implementation |
|--------------|---------|----------------|
| **Research Database** | âœ… Shared | Same 698 studies, translated metadata |
| **Glossary** | âœ… Shared structure | 251 terms, translated definitions |
| **Tools** | âœ… Shared logic | Translated UI labels |
| **Condition Articles** | ğŸ”„ Localized | Same topics, market-adapted content |
| **Product Articles** | ğŸ”„ Localized | Same topics, market-adapted |
| **Legal Articles** | âŒ Unique | 100% market-specific |
| **Brand Reviews** | ğŸ”„ Mixed | International core + local brands |
| **News** | âŒ Unique | Market-specific news |
| **Newsletter** | âŒ Unique | Separate list per market |

### 4.5 URL Structure

**Translated slugs per language** (recommended for SEO):

| Page | English | Danish | German |
|------|---------|--------|--------|
| CBD and Anxiety | /cbd-and-anxiety | /cbd-og-angst | /cbd-und-angst |
| Dosage Guide | /cbd-dosage-guide | /cbd-dosering-guide | /cbd-dosierung-anleitung |
| Brand Reviews | /reviews | /anmeldelser | /bewertungen |

---

# PART 2: CONTENT STRATEGY

---

## 5. CONTENT OVERVIEW

### 5.1 The CBD Portal Ecosystem

```
                                CBD PORTAL
                                    â”‚
    â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
    â”‚              â”‚                â”‚                â”‚              â”‚
KNOWLEDGE      RESEARCH          BRANDS           TOOLS        GLOSSARY
850 articles   698 studies     100+ reviews     7+ tools      251 terms
    â”‚              â”‚                â”‚                â”‚              â”‚
    â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                                    â”‚
                    â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
                         ALL INTERCONNECTED VIA
                           INTERNAL LINKING
                    â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
```

### 5.2 Content Assets Summary

| Content Type | Count | Status |
|--------------|-------|--------|
| Knowledge Base Articles | 850 | Planned |
| Research Studies | 698 | âœ… Complete |
| Brand Reviews | 100+ | In Progress |
| Glossary Terms | 251 | âœ… Complete |
| Interactive Tools | 7+ | 2 Live, 5+ Planned |
| **Total Pages** | **~1,900** | |

### 5.3 Category Architecture

| # | Category | Articles | Purpose |
|---|----------|----------|---------|
| 1 | Foundations & Basics | 50 | Entry points, beginner education |
| 2 | Cannabinoids | 40 | Compound deep-dives |
| 3 | Terpenes | 30 | Aromatic compound profiles |
| 4 | Products | 40 | Product type guides |
| 5 | **Conditions & Health** | **280** | CBD + condition articles |
| 6 | **Pets** | **80** | Animal-specific content |
| 7 | Guides & How-To | 55 | Practical instruction |
| 8 | Science & Research | 45 | Evidence-based content |
| 9 | Safety & Quality | 40 | Trust-building |
| 10 | Comparisons | 55 | VS articles |
| 11 | Legal & Regulations | 50 | Compliance content |
| 12 | Demographics | 25 | Audience-specific |
| 13 | Hemp & Cultivation | 25 | Sourcing & sustainability |
| 14 | FAQ & Common Questions | 35 | Long-tail capture |
| | **TOTAL** | **850** | |

### 5.4 Content Depth Tiers

| Tier | Word Count | Articles | Purpose |
|------|------------|----------|---------|
| **Pillar** | 4,000-6,000 | 30 | Comprehensive authority |
| **Core** | 2,000-3,000 | 200 | Main topic coverage |
| **Standard** | 1,500-2,000 | 400 | Solid coverage |
| **Quick** | 800-1,200 | 220 | FAQ, simple topics |

---

## 6. WAVE PUBLISHING MODEL

### 6.1 The Problem with Random Publishing

Publishing randomly across categories fails to build topical authority. Google rewards sites that demonstrate **comprehensive expertise** on a subject.

**Topical Authority Signals:**
- âœ… Cover ALL subtopics within a cluster
- âœ… Interlink extensively within clusters
- âœ… Clear pillar â†’ cluster hierarchy
- âœ… No gaps that signal incomplete coverage
- âœ… Consistent publishing within topic areas
- âŒ Random topic jumping
- âŒ Thin coverage of important subtopics
- âŒ Orphan pages with no internal links

### 6.2 Wave Publishing Strategy

Instead of publishing randomly, publish in **topical waves** that build authority systematically:

```
WAVE PUBLISHING MODEL

Week 1-2: FOUNDATION WAVE
â”œâ”€â”€ All "What is X" articles (30)
â”œâ”€â”€ Core concepts (20)
â”œâ”€â”€ Establishes basic topical coverage
â””â”€â”€ Creates linking foundation

Week 3-4: CANNABINOID WAVE  
â”œâ”€â”€ All cannabinoid profiles (40)
â”œâ”€â”€ All cannabinoid comparisons (18)
â”œâ”€â”€ Heavy internal linking
â””â”€â”€ Establishes compound expertise

Week 5-6: MENTAL HEALTH WAVE
â”œâ”€â”€ Pillar: CBD and Mental Health
â”œâ”€â”€ All 30 mental health conditions
â”œâ”€â”€ Related: Dosage for anxiety, Best terpenes for anxiety
â”œâ”€â”€ Link cluster tightly together
â””â”€â”€ Google sees "this site owns CBD + mental health"

Week 7-8: PAIN WAVE
â”œâ”€â”€ Pillar: CBD and Pain  
â”œâ”€â”€ All 35 pain conditions
â”œâ”€â”€ Related: Topicals guide, Sports recovery
â”œâ”€â”€ Cross-link to mental health where relevant
â””â”€â”€ Authority expands to adjacent topic

Week 9-10: SLEEP WAVE
â”œâ”€â”€ Pillar: CBD and Sleep
â”œâ”€â”€ All 15 sleep conditions
â”œâ”€â”€ Related: CBN articles, nighttime routines
â””â”€â”€ Cross-link to anxiety (overlap)

[Continue pattern for remaining waves...]
```

### 6.3 Complete Wave Schedule

| Wave | Weeks | Articles | Topics |
|------|-------|----------|--------|
| 1. Foundation | 1-2 | 50 | Basics, core concepts, ECS |
| 2. Cannabinoids | 3-4 | 58 | All cannabinoid profiles + comparisons |
| 3. Mental Health | 5-6 | 35 | Anxiety, depression, stress, PTSD, etc. |
| 4. Pain | 7-8 | 40 | All pain conditions + topicals |
| 5. Sleep | 9-10 | 20 | Sleep conditions + CBN content |
| 6. Inflammation | 11-12 | 30 | Arthritis, autoimmune, IBD |
| 7. Neurological | 13-14 | 25 | Epilepsy, Parkinson's, neuropathy |
| 8. Products | 15-16 | 45 | All product types + comparisons |
| 9. Pets | 17-18 | 80 | All pet content by animal |
| 10. Skin & Beauty | 19-20 | 30 | Skin conditions + skincare |
| 11. Guides | 21-22 | 55 | How-to, dosing, getting started |
| 12. Safety | 23-24 | 40 | Side effects, interactions, quality |
| 13. Legal | 25-26 | 50 | All country-specific legal content |
| 14. Terpenes | 27-28 | 30 | Terpene profiles + applications |
| 15. Science | 29-30 | 45 | Research, studies, mechanisms |
| 16. Remaining | 31-34 | 217 | Comparisons, demographics, FAQ, hemp |

### 6.4 Why Wave Publishing Works

| Benefit | Mechanism |
|---------|-----------|
| **Topical authority** | Google sees concentrated expertise |
| **Better crawling** | Related content indexed together |
| **Natural linking** | Easy to interlink within waves |
| **Quality control** | Focus on one topic = better research |
| **User journeys** | Readers can explore related content |
| **Momentum** | Complete clusters = visible progress |

---

## 7. CONTENT DEPTH FRAMEWORK

### 7.1 Match Intent, Not Arbitrary Length

**The myth:** "Longer content ranks better"  
**The truth:** Content that **best satisfies search intent** ranks better

### 7.2 Intent-Based Depth Guide

| Query Type | Example | User Intent | Optimal Words | Depth |
|------------|---------|-------------|---------------|-------|
| **Definitional** | "What is CBD" | Quick understanding | 800-1,200 | Overview |
| **Quick Answer** | "Does CBD make you tired" | Yes/no + brief explanation | 600-900 | Surface |
| **Condition** | "CBD for anxiety" | Research + guidance | 1,800-2,500 | Moderate |
| **Comparison** | "CBD vs THC" | Side-by-side analysis | 1,500-2,000 | Thorough |
| **How-To** | "How to take CBD oil" | Step-by-step instruction | 1,200-1,800 | Practical |
| **Buying** | "Best CBD oil for sleep" | Recommendations | 2,000-2,500 | Comparative |
| **Legal** | "Is CBD legal in Germany" | Current facts + nuance | 1,200-1,800 | Factual |
| **Pillar** | "Complete guide to CBD" | Comprehensive reference | 4,000-6,000 | Deep |

### 7.3 Revised Depth Tiers

| Tier | Articles | Word Count | Purpose | Production Time |
|------|----------|------------|---------|-----------------|
| **Quick Answer** | 100 | 600-900 | FAQ, simple questions | 15-20 min |
| **Standard** | 400 | 1,200-1,800 | Core informational | 30-45 min |
| **Comprehensive** | 300 | 1,800-2,500 | Conditions, guides | 45-60 min |
| **Pillar** | 50 | 3,500-5,500 | Ultimate guides | 90-120 min |

### 7.4 Depth by Category

| Category | Primary Depth | Rationale |
|----------|---------------|-----------|
| Foundations | Standard | Educational, not deep research |
| Cannabinoids | Standard | Scientific profiles |
| Conditions | Comprehensive | Research + guidance needed |
| Products | Standard | Practical information |
| Comparisons | Standard | Side-by-side focus |
| Guides | Standard-Comprehensive | Actionable content |
| Legal | Standard | Factual, changes often |
| FAQ | Quick Answer | Direct answers |
| Pillars | Pillar | Comprehensive authority |

---

## 8. KEYWORD VALIDATION PROCESS

### 8.1 Why Validate Keywords

The 850-article plan was built on intuition. Before producing each wave, validate:

| Gap Without Validation | Risk |
|------------------------|------|
| No search volume data | Writing articles nobody searches for |
| No keyword difficulty | Targeting impossible keywords |
| No competitor gaps | Missing easy wins |
| No intent mapping | Wrong content type for query |

### 8.2 Validation Workflow

```
KEYWORD VALIDATION WORKFLOW (Per Wave)

1. EXTRACT PLANNED KEYWORDS
   â””â”€â”€ Pull all keywords from upcoming wave

2. GET SEARCH DATA
   â”œâ”€â”€ Monthly search volume (per country: UK, DE, DK)
   â”œâ”€â”€ Keyword difficulty score
   â”œâ”€â”€ Current SERP analysis
   â””â”€â”€ Related keywords/PAA questions

3. ANALYZE GAPS
   â”œâ”€â”€ What do competitors rank for that we don't have?
   â”œâ”€â”€ What PAA questions aren't in our list?
   â””â”€â”€ What long-tail variations exist?

4. PRIORITIZE
   â”œâ”€â”€ High volume + Low difficulty = Priority 1
   â”œâ”€â”€ High volume + High difficulty = Needs pillar support first
   â”œâ”€â”€ Low volume + Low difficulty = Easy wins, batch together
   â””â”€â”€ Low volume + High difficulty = Skip or deprioritize

5. ADJUST PLAN
   â”œâ”€â”€ Add missing high-opportunity keywords
   â”œâ”€â”€ Remove zero-volume topics
   â”œâ”€â”€ Merge similar topics into single articles
   â””â”€â”€ Adjust content depth based on SERP analysis
```

### 8.3 Prioritization Matrix

| | Low Difficulty | High Difficulty |
|---|----------------|-----------------|
| **High Volume** | ğŸ¥‡ Priority 1 â€” Do first | ğŸ¥ˆ Priority 2 â€” Need pillar support |
| **Low Volume** | ğŸ¥‰ Priority 3 â€” Batch together | âŒ Skip â€” Not worth effort |

### 8.4 Tools for Validation

| Tool | Purpose | Data Provided |
|------|---------|---------------|
| Ahrefs / SEMrush | Keyword research | Volume, difficulty, SERP |
| Google Search Console | Existing rankings | Impressions, clicks, position |
| AlsoAsked / AnswerThePublic | PAA questions | Related questions |
| Competitor analysis | Gap identification | What others rank for |

---

## 9. CONTENT PRODUCTION PIPELINE

### 9.1 Pipeline Overview

```
CONTENT PRODUCTION PIPELINE

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ PHASE 1: RESEARCH (Per Wave)                                â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ â€¢ Keyword validation                                        â”‚
â”‚ â€¢ Competitor content audit                                  â”‚
â”‚ â€¢ Research database query (relevant studies)                â”‚
â”‚ â€¢ Outline creation                                          â”‚
â”‚ â€¢ Internal linking plan                                     â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                              â”‚
                              â–¼
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ PHASE 2: PRODUCTION                                         â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ â€¢ AI draft generation (structured prompt + guidelines)      â”‚
â”‚ â€¢ Fact verification against research database               â”‚
â”‚ â€¢ Medical language compliance check                         â”‚
â”‚ â€¢ Internal link insertion                                   â”‚
â”‚ â€¢ SEO optimization (title, meta, headers)                   â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                              â”‚
                              â–¼
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ PHASE 3: REVIEW                                             â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ â€¢ Expert review (medical claims accuracy)                   â”‚
â”‚ â€¢ Editorial review (quality, voice, readability)            â”‚
â”‚ â€¢ SEO review (technical requirements)                       â”‚
â”‚ â€¢ Final approval                                            â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                              â”‚
                              â–¼
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ PHASE 4: PUBLISH                                            â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ â€¢ Schedule per wave plan                                    â”‚
â”‚ â€¢ Submit to Google Search Console                           â”‚
â”‚ â€¢ Add to internal link network                              â”‚
â”‚ â€¢ Queue for translation (DA, DE)                            â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                              â”‚
                              â–¼
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ PHASE 5: MONITOR                                            â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ â€¢ Track rankings at 7/14/30/90 days                         â”‚
â”‚ â€¢ Identify underperformers                                  â”‚
â”‚ â€¢ Update/expand as needed                                   â”‚
â”‚ â€¢ Feed learnings back to process                            â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### 9.2 Production Roles

| Role | Responsibility | Volume |
|------|----------------|--------|
| **Content Strategist** | Wave planning, keyword validation | Per wave |
| **AI + Editor** | Draft generation, editing | 10-15 articles/day |
| **Medical Reviewer** | Fact-check health claims | All condition articles |
| **SEO Reviewer** | Technical optimization | All articles |
| **Translator** | DA/DE localization | Follows EN by 1-2 weeks |

### 9.3 Quality Gates

| Gate | Criteria | Blocker? |
|------|----------|----------|
| **Draft Complete** | All sections present, word count met | Yes |
| **Fact Check** | Medical claims verified against research | Yes |
| **SEO Check** | Title, meta, headers, links optimized | Yes |
| **Editorial** | Voice, readability, formatting | Yes |
| **Final Approval** | Ready for publication | Yes |

---

## 10. THREE-MARKET LAUNCH PLAN

### 6.1 Launch Sequence

| Phase | Market | Domain | Language | Priority |
|-------|--------|--------|----------|----------|
| **Phase 1** | International | TBD | English | Foundation |
| **Phase 2** | Denmark | CBD.dk | Danish | First localization |
| **Phase 3** | Germany | CBD.de | German | Largest market |

### 6.2 Phase 1: International English

**Goal:** Establish the foundation with complete English content

| Milestone | Content | Target |
|-----------|---------|--------|
| Launch | Core 200 articles | Foundations, top conditions, products |
| Month 2 | +150 articles | Remaining conditions |
| Month 3 | +200 articles | Guides, safety, science |
| Month 4-5 | +200 articles | Comparisons, legal, FAQ |
| Month 6 | +100 articles | Demographics, hemp, remaining |
| **Total** | **850 articles** | Complete English library |

**Also required for Phase 1:**
- 50+ brand reviews with full scores
- All tools functional
- Newsletter launched
- Complete research database integration

### 6.3 Phase 2: Danish (CBD.dk)

**Trigger:** Phase 1 core content complete (200+ articles)

| Content Type | Approach | Volume |
|--------------|----------|--------|
| Condition Articles | Localize from English | 280 |
| Product Articles | Localize from English | 40 |
| Legal Content | **Create unique** | 5-10 (Denmark-specific) |
| Brand Reviews | Add Danish brands | +15-25 local brands |
| News | **Create unique** | Ongoing |
| Newsletter | **Create unique** | Weekly |

**Danish-Specific Content:**
- Is CBD Legal in Denmark? (comprehensive)
- Danish CBD Regulations Explained
- Where to Buy CBD in Denmark
- Danish CBD Brand Directory
- CBD and Danish Healthcare System

### 6.4 Phase 3: German (CBD.de)

**Trigger:** Phase 2 launched and stable

| Content Type | Approach | Volume |
|--------------|----------|--------|
| Condition Articles | Localize from English | 280 |
| Product Articles | Localize from English | 40 |
| Legal Content | **Create unique** | 10-15 (Germany-specific) |
| Brand Reviews | Add German brands | +30-50 local brands |
| News | **Create unique** | Ongoing |
| Newsletter | **Create unique** | Weekly |

**German-Specific Content:**
- Is CBD Legal in Germany? (comprehensive)
- German Novel Food Regulations
- CBD in German Pharmacies
- German CBD Brand Directory
- CBD and German Health Insurance
- Buying CBD in Germany: Complete Guide
- German Hemp Industry Overview

### 6.5 Localization vs. Translation

| Element | Translation (âŒ) | Localization (âœ…) |
|---------|-----------------|------------------|
| "CBD is legal in most of Europe" | Direct translation | Market-specific legal status |
| Brand examples | Same brands | Feature local brands prominently |
| Regulatory references | EU regulations only | Country-specific regulations |
| Expert quotes | International only | Include local researchers/doctors |
| Cultural references | Generic | Market-appropriate examples |
| Price examples | EUR generic | Local pricing context |
| Purchasing advice | Generic EU | Where to buy locally |

---

## 7. COMPLETE ARTICLE LIST

### CATEGORY 1: FOUNDATIONS & BASICS (50 articles)

#### Pillar Articles (8)

| # | Title | Slug | Words |
|---|-------|------|-------|
| 1 | Introduction to CBD: The Complete Guide | introduction-to-cbd | 4,000 |
| 2 | The Beginner's Guide to CBD | beginners-guide-to-cbd | 4,000 |
| 3 | How CBD Works in the Body | how-cbd-works | 3,500 |
| 4 | The Endocannabinoid System Explained | endocannabinoid-system | 4,000 |
| 5 | The History of CBD and Cannabis | history-of-cbd | 3,000 |
| 6 | CBD Buying Guide: Everything You Need to Know | cbd-buying-guide | 4,000 |
| 7 | Understanding CBD Quality | understanding-cbd-quality | 3,500 |
| 8 | CBD and Your Body: A Complete Overview | cbd-and-your-body | 3,500 |

#### Core Concepts (15)

| # | Title | Slug |
|---|-------|------|
| 9 | What is CBD? | what-is-cbd |
| 10 | What is Hemp? | what-is-hemp |
| 11 | Hemp vs Marijuana: What's the Difference? | hemp-vs-marijuana |
| 12 | What is Cannabis? | what-is-cannabis |
| 13 | What is Full Spectrum CBD? | what-is-full-spectrum-cbd |
| 14 | What is Broad Spectrum CBD? | what-is-broad-spectrum-cbd |
| 15 | What is CBD Isolate? | what-is-cbd-isolate |
| 16 | Full Spectrum vs Broad Spectrum vs Isolate | full-spectrum-vs-broad-spectrum-vs-isolate |
| 17 | The Entourage Effect Explained | entourage-effect |
| 18 | What Are Cannabinoids? | what-are-cannabinoids |
| 19 | What Are Terpenes? | what-are-terpenes |
| 20 | What Are Flavonoids? | what-are-flavonoids |
| 21 | Phytocannabinoids vs Endocannabinoids | phytocannabinoids-vs-endocannabinoids |
| 22 | Hemp Extract vs CBD | hemp-extract-vs-cbd |
| 23 | Cannabis Sativa vs Indica vs Ruderalis | cannabis-sativa-indica-ruderalis |

#### Endocannabinoid System Deep-Dives (10)

| # | Title | Slug |
|---|-------|------|
| 24 | What Are CB1 Receptors? | cb1-receptors |
| 25 | What Are CB2 Receptors? | cb2-receptors |
| 26 | What is Anandamide? | what-is-anandamide |
| 27 | What is 2-AG? | what-is-2-ag |
| 28 | What is the GPR55 Receptor? | gpr55-receptor |
| 29 | What Are TRPV Receptors? | trpv-receptors |
| 30 | What is FAAH? | what-is-faah |
| 31 | Endocannabinoid Deficiency | endocannabinoid-deficiency |
| 32 | How to Support Your Endocannabinoid System | support-endocannabinoid-system |
| 33 | The Endocannabinoid System and Homeostasis | ecs-and-homeostasis |

#### Beginner Questions (17)

| # | Title | Slug |
|---|-------|------|
| 34 | Does CBD Get You High? | does-cbd-get-you-high |
| 35 | Is CBD Psychoactive? | is-cbd-psychoactive |
| 36 | What Does CBD Feel Like? | what-does-cbd-feel-like |
| 37 | Is CBD Natural? | is-cbd-natural |
| 38 | Where Does CBD Come From? | where-does-cbd-come-from |
| 39 | How is CBD Made? | how-is-cbd-made |
| 40 | Is CBD a Drug? | is-cbd-a-drug |
| 41 | Is CBD Medicine? | is-cbd-medicine |
| 42 | Can Anyone Take CBD? | can-anyone-take-cbd |
| 43 | How Old Do You Have to Be to Buy CBD? | age-to-buy-cbd |
| 44 | Is CBD Halal? | is-cbd-halal |
| 45 | Is CBD Kosher? | is-cbd-kosher |
| 46 | Is CBD Vegan? | is-cbd-vegan |
| 47 | Common CBD Myths Debunked | cbd-myths-debunked |
| 48 | CBD Terminology Glossary | cbd-terminology-glossary |
| 49 | What CBD Skeptics Get Wrong | cbd-skeptics |
| 50 | Why People Use CBD | why-people-use-cbd |

---

### CATEGORY 2: CANNABINOIDS (40 articles)

#### Major Cannabinoids (10)

| # | Title | Slug |
|---|-------|------|
| 51 | What is CBD (Cannabidiol)? Complete Guide | what-is-cannabidiol |
| 52 | What is THC (Tetrahydrocannabinol)? | what-is-thc |
| 53 | What is CBG (Cannabigerol)? | what-is-cbg |
| 54 | What is CBN (Cannabinol)? | what-is-cbn |
| 55 | What is CBC (Cannabichromene)? | what-is-cbc |
| 56 | What is CBDA (Cannabidiolic Acid)? | what-is-cbda |
| 57 | What is THCA (Tetrahydrocannabinolic Acid)? | what-is-thca |
| 58 | What is CBGA (Cannabigerolic Acid)? | what-is-cbga |
| 59 | What is Delta-8-THC? | what-is-delta-8-thc |
| 60 | What is Delta-9-THC? | what-is-delta-9-thc |

#### Minor & Emerging Cannabinoids (12)

| # | Title | Slug |
|---|-------|------|
| 61 | What is THCV (Tetrahydrocannabivarin)? | what-is-thcv |
| 62 | What is CBDV (Cannabidivarin)? | what-is-cbdv |
| 63 | What is CBE (Cannabielsoin)? | what-is-cbe |
| 64 | What is CBL (Cannabicyclol)? | what-is-cbl |
| 65 | What is CBT (Cannabitriol)? | what-is-cbt-cannabinoid |
| 66 | What is HHC (Hexahydrocannabinol)? | what-is-hhc |
| 67 | What is THC-O (THC-O-Acetate)? | what-is-thc-o |
| 68 | What is Delta-10-THC? | what-is-delta-10-thc |
| 69 | What is THCP? | what-is-thcp |
| 70 | What is CBDP? | what-is-cbdp |
| 71 | What Are Minor Cannabinoids? | minor-cannabinoids |
| 72 | Synthetic Cannabinoids: Why to Avoid Them | synthetic-cannabinoids-dangers |

#### Cannabinoid Comparisons (18)

| # | Title | Slug |
|---|-------|------|
| 73 | CBD vs THC: Complete Comparison | cbd-vs-thc |
| 74 | CBD vs CBDA | cbd-vs-cbda |
| 75 | THC vs THCA | thc-vs-thca |
| 76 | CBD vs CBG | cbd-vs-cbg |
| 77 | CBD vs CBN | cbd-vs-cbn |
| 78 | CBD vs CBC | cbd-vs-cbc |
| 79 | CBD vs Delta-8 | cbd-vs-delta-8 |
| 80 | CBG vs CBN | cbg-vs-cbn |
| 81 | CBG vs CBGA | cbg-vs-cbga |
| 82 | Delta-8 vs Delta-9 THC | delta-8-vs-delta-9 |
| 83 | Delta-8 vs Delta-10 THC | delta-8-vs-delta-10 |
| 84 | HHC vs THC | hhc-vs-thc |
| 85 | HHC vs Delta-8 | hhc-vs-delta-8 |
| 86 | THC-O vs Delta-8 | thc-o-vs-delta-8 |
| 87 | CBD vs HHC | cbd-vs-hhc |
| 88 | CBN vs Melatonin for Sleep | cbn-vs-melatonin |
| 89 | Raw vs Decarboxylated Cannabinoids | raw-vs-decarboxylated-cannabinoids |
| 90 | All Cannabinoids Compared | all-cannabinoids-compared |

---

### CATEGORY 3: TERPENES (30 articles)

#### Terpene Overview (5)

| # | Title | Slug |
|---|-------|------|
| 91 | What Are Terpenes? Complete Guide | what-are-terpenes-guide |
| 92 | Terpenes and CBD: Why They Matter | terpenes-and-cbd |
| 93 | How Terpenes Affect CBD | how-terpenes-affect-cbd |
| 94 | Terpene Profiles Explained | terpene-profiles |
| 95 | Terpenes vs Cannabinoids | terpenes-vs-cannabinoids |

#### Individual Terpene Profiles (20)

| # | Title | Slug |
|---|-------|------|
| 96-115 | [Myrcene, Limonene, Linalool, Pinene, Caryophyllene, Humulene, Terpinolene, Ocimene, Bisabolol, Eucalyptol, Geraniol, Nerolidol, Valencene, Borneol, Camphene, Guaiol, Terpineol, Phytol, Sabinene, Cymene] | [terpene-name] |

#### Terpene Applications (5)

| # | Title | Slug |
|---|-------|------|
| 116 | Best Terpenes for Sleep | best-terpenes-for-sleep |
| 117 | Best Terpenes for Anxiety | best-terpenes-for-anxiety |
| 118 | Best Terpenes for Pain | best-terpenes-for-pain |
| 119 | Best Terpenes for Focus | best-terpenes-for-focus |
| 120 | Best Terpenes for Energy | best-terpenes-for-energy |

---

### CATEGORY 4: PRODUCTS (40 articles)

#### Product Type Guides (25)

| # | Title | Slug |
|---|-------|------|
| 121-145 | [CBD Oil, Gummies, Capsules, Softgels, Cream, Balm, Salve, Lotion, Topicals, Tincture, Vape, Vape Pen, Vape Cartridge, E-Liquid, Flower, Pre-Rolls, Edibles, Patches, Drinks, Coffee, Tea, Bath Bombs, Skincare, Lip Balm, Concentrates] | [product-type]-guide |

#### Product Deep-Dives (10)

| # | Title | Slug |
|---|-------|------|
| 146-155 | [Water-Soluble CBD, Nano CBD, Liposomal CBD, CBD Hash, CBD Shatter, CBD Wax, CBD Crumble, CBD Distillate, CBD Crude Oil, RSO] | [product-type] |

#### Product Components (5)

| # | Title | Slug |
|---|-------|------|
| 156 | CBD Carrier Oils Explained | cbd-carrier-oils |
| 157 | MCT Oil in CBD Products | mct-oil-cbd |
| 158 | Hemp Seed Oil vs CBD Oil | hemp-seed-oil-vs-cbd-oil |
| 159 | Flavored vs Unflavored CBD Oil | flavored-vs-unflavored-cbd |
| 160 | CBD Oil Strength Guide | cbd-oil-strength-guide |

---

### CATEGORY 5: CONDITIONS & HEALTH (280 articles)

#### 5.1 Mental Health (30)
CBD and: Anxiety, Social Anxiety, GAD, Panic Attacks, Panic Disorder, Stress, Chronic Stress, Depression, PTSD, OCD, Bipolar Disorder, Mood Disorders, Mood Swings, SAD, Phobias, Nervousness, Irritability, Emotional Wellbeing, Mental Health, Relaxation, Calm, Focus, Concentration, ADHD, ADD, Autism, Schizophrenia, Psychosis, Burnout, Work Stress

#### 5.2 Sleep (15)
CBD and: Sleep, Insomnia, Sleep Quality, Sleep Apnea, Restless Leg Syndrome, Jet Lag, Night Terrors, Nightmares, Circadian Rhythm, Nighttime Anxiety, Dreams, REM Sleep, Snoring, Shift Work Sleep Disorder, Sleeping Pills

#### 5.3 Pain (35)
CBD and: Pain, Chronic Pain, Acute Pain, Back Pain, Lower Back Pain, Upper Back Pain, Neck Pain, Shoulder Pain, Joint Pain, Knee Pain, Hip Pain, Elbow Pain, Wrist Pain, Hand Pain, Foot Pain, Muscle Pain, Muscle Soreness, DOMS, Nerve Pain, Neuropathic Pain, Sciatica, Headaches, Migraines, Tension Headaches, Cluster Headaches, Menstrual Cramps, Period Pain, TMJ, Jaw Pain, Toothache, Dental Pain, Post-Surgery Pain, Plantar Fasciitis, Carpal Tunnel, Tennis Elbow

#### 5.4 Inflammation & Autoimmune (25)
CBD and: Inflammation, Chronic Inflammation, Arthritis, Rheumatoid Arthritis, Osteoarthritis, Psoriatic Arthritis, Gout, Lupus, Multiple Sclerosis, Crohn's Disease, Ulcerative Colitis, IBD, IBS, Celiac Disease, Hashimoto's, Graves' Disease, Autoimmune Disorders, Polymyalgia Rheumatica, SjÃ¶gren's Syndrome, Ankylosing Spondylitis, Raynaud's Syndrome, Bursitis, Tendonitis, Immune System, Immunosuppression

#### 5.5 Neurological (25)
CBD and: Epilepsy, Seizures, Dravet Syndrome, Lennox-Gastaut Syndrome, Tuberous Sclerosis, Parkinson's Disease, Alzheimer's Disease, Dementia, Vascular Dementia, ALS, Huntington's Disease, Tremors, Essential Tremor, Neuropathy, Peripheral Neuropathy, Diabetic Neuropathy, Tourette Syndrome, Tics, Brain Health, Neuroprotection, Trigeminal Neuralgia, Brain Fog, Memory, Cognitive Function, Concussion Recovery

#### 5.6 Skin (22)
CBD and: Skin Health, Acne, Cystic Acne, Hormonal Acne, Eczema, Psoriasis, Dermatitis, Atopic Dermatitis, Rosacea, Dry Skin, Oily Skin, Aging Skin, Wrinkles, Fine Lines, Skin Inflammation, Wound Healing, Burns, Sunburn, Itchy Skin, Hives, Vitiligo, Keratosis Pilaris

#### 5.7 Hair & Scalp (8)
CBD and: Hair Health, Hair Loss, Alopecia, Hair Growth, Scalp Health, Dandruff, Dry Scalp, Scalp Psoriasis

#### 5.8 Digestive (18)
CBD and: Digestive Health, Nausea, Vomiting, Appetite, Loss of Appetite, Increased Appetite, Bloating, Gas, GERD, Acid Reflux, Heartburn, Gastroparesis, Stomach Problems, Gut Health, Leaky Gut, Constipation, Diarrhea, Gastritis

#### 5.9 Cardiovascular (12)
CBD and: Heart Health, Blood Pressure, High Blood Pressure, Low Blood Pressure, Circulation, Cholesterol, Heart Palpitations, Arrhythmia, Varicose Veins, PAD, Stroke Recovery, Raynaud's Phenomenon

#### 5.10 Respiratory (10)
CBD and: Respiratory Health, Asthma, COPD, Bronchitis, Sinusitis, Allergies, Hay Fever, Shortness of Breath, Cough, Lung Health

#### 5.11 Women's Health (18)
CBD and: Women's Health, Menopause, Perimenopause, PMS, PMDD, PCOS, Endometriosis, Adenomyosis, Hormonal Imbalance, Hot Flashes, Night Sweats, Hormonal Mood Swings, Female Fertility, Pregnancy, Breastfeeding, Postpartum, Vaginal Dryness, Pelvic Pain

#### 5.12 Men's Health (12)
CBD and: Men's Health, Erectile Dysfunction, Testosterone, Male Fertility, Prostate Health, BPH, Prostatitis, Low Libido (Men), Male Pattern Baldness, Gynecomastia, Performance Anxiety, Sexual Health (Men)

#### 5.13 Sexual Health (8)
CBD and: Sexual Health, Libido, Sex, Sexual Dysfunction, Intimacy, Arousal, Orgasm, CBD Lubricants

#### 5.14 Eye & Ear (8)
CBD and: Eye Health, Glaucoma, Eye Pressure, Dry Eyes, Vision, Tinnitus, Hearing Loss, Vertigo

#### 5.15 Oral Health (8)
CBD and: Oral Health, Gum Disease, Gingivitis, Periodontitis, Bruxism, Jaw Clenching, Bad Breath, Mouth Ulcers

#### 5.16 Bone & Joint (8)
CBD and: Bone Health, Osteoporosis, Osteopenia, Bone Density, Bone Fractures, Bone Healing, Herniated Disc, Degenerative Disc Disease

#### 5.17 Cancer Support (10)
CBD and: Cancer Support, Chemotherapy Side Effects, Radiation Side Effects, Cancer-Related Pain, Cancer-Related Nausea, Cancer-Related Anxiety, Cancer Cachexia, Palliative Care, Terminal Illness, End-of-Life Care

#### 5.18 Addiction & Substance (10)
CBD and: Addiction, Alcohol Addiction, Alcohol Withdrawal, Opioid Addiction, Opioid Withdrawal, Smoking Cessation, Nicotine Addiction, Drug Withdrawal, Substance Use Disorder, Cannabis Use Disorder

#### 5.19 Metabolic & Diabetes (10)
CBD and: Diabetes, Type 1 Diabetes, Type 2 Diabetes, Blood Sugar, Insulin Resistance, Metabolic Syndrome, Weight, Weight Loss, Obesity, Metabolism

#### 5.20 Aging & Longevity (8)
CBD and: Healthy Aging, Longevity, Cognitive Decline, Age-Related Conditions, Frailty, Sarcopenia, Anti-Aging, Cellular Health

#### 5.21 Sports & Recovery (12)
CBD and: Sports Recovery, Muscle Recovery, Exercise, Athletic Performance, Endurance, Pre-Workout, Post-Workout, Sports Injuries, Sprains, Strains, Runner's Knee, Shin Splints

#### 5.22 Children & Pediatric (8)
CBD for Children, Pediatric Epilepsy, Children's Anxiety, ADHD in Children, Autism in Children, Sleep Problems in Children, CBD Dosing for Children, Is CBD Safe for Children?

#### 5.23 Other Conditions (10)
CBD and: Chronic Fatigue Syndrome, Fibromyalgia, Lyme Disease, Long COVID, Thyroid Disorders, Hypothyroidism, Hyperthyroidism, Sickle Cell Disease, Energy, Fatigue

---

### CATEGORY 6: PETS (80 articles)

#### General Pet Content (12)
CBD for Pets, Is CBD Safe for Pets?, Pet Endocannabinoid System, How to Give CBD to Pets, CBD Pet Dosage Guide, Pet CBD Product Types, CBD Pet Treats vs Oil, How to Choose CBD for Pets, CBD Pet Product Safety, What Vets Say About CBD, CBD for Pet Fireworks Anxiety, CBD for Pet Travel Anxiety

#### Dogs (25)
Complete coverage of CBD for dogs including anxiety, arthritis, seizures, pain, cancer, allergies, skin issues, senior dogs, puppies, and breed-specific considerations.

#### Cats (18)
Complete coverage of CBD for cats including anxiety, arthritis, pain, seizures, kidney disease, hyperthyroidism, IBD, senior cats, and kittens.

#### Horses (12)
Complete coverage of CBD for horses including anxiety, arthritis, colic, laminitis, navicular, sweet itch, and competition rules.

#### Birds (6)
CBD for Birds, Safety, Dosage, Parrot Anxiety, Feather Plucking, Bird Stress

#### Small Animals (7)
CBD for Rabbits, Guinea Pigs, Hamsters, Ferrets, Small Animals Safety Guide, Small Animals Dosage

---

### CATEGORY 7: GUIDES & HOW-TO (55 articles)

#### Getting Started (12)
How to Start Taking CBD, Choose a Product, Choose a Brand, Buy Online, Buy in Store, What to Expect, Set Goals, Track Effects, Keep a CBD Journal, Talk to Your Doctor, Tell Family, First Week on CBD

#### Dosing Guides (15)
CBD Dosage Guide, Find Your Dosage, Dosage by Weight, Dosage for Beginners, Dosage for Sleep, Dosage for Anxiety, Dosage for Pain, Starting Dose, Maintenance Dose, Microdosing CBD, CBD Titration, When to Increase Dose, When to Decrease Dose, mg/mL Calculator Guide, Percentage to mg Conversion

#### Usage Guides (15)
How to Take CBD Oil, Use Drops, Take Sublingually, Use Gummies, Take Capsules, Apply Cream, Apply Topicals, Vape CBD, Use Patches, Use Flower, How Long to Work, How Long Does CBD Last, How Long in System, Best Time to Take, Morning vs Night

#### Quality & Safety Guides (8)
Read Labels, Read Lab Reports, Verify Quality, Check Potency, Spot Fake CBD, Store Products, Travel with CBD, Dispose of CBD

#### Consumption Method Guides (5)
Consumption Methods Compared, Sublingual CBD, Oral CBD Guide, Topical CBD Guide, Inhaled CBD Guide

---

### CATEGORY 8: SCIENCE & RESEARCH (45 articles)

#### CBD Science (15)
Science of CBD, How CBD Affects the Brain, Nervous System, Pharmacology, Pharmacokinetics, How Metabolized, Bioavailability, First-Pass Metabolism, Half-Life, Serotonin Receptors, GABA Receptors, Dopamine, Anti-Inflammatory Mechanisms, Antioxidant Properties, Homeostasis

#### Research Overview (10)
CBD Research Overview, Clinical Research, Clinical Trials, Understanding Studies, Why CBD Works Differently, Genetics, Research Limitations, Placebo Effect, Future of Research, How to Read Research

#### Landmark Studies (10)
Epidiolex, Charlotte's Web Story, Key Anxiety Studies, Key Pain Studies, Key Sleep Studies, Key Epilepsy Studies, Inflammation Research, Neuroprotection Research, Skin Research, Mental Health Research

#### Production Science (10)
Extraction Methods, CO2 Extraction, Ethanol Extraction, Hydrocarbon Extraction, Solventless Extraction, Distillation, Winterization, Decarboxylation, Chromatography, How Products Are Made

---

### CATEGORY 9: SAFETY & QUALITY (40 articles)

#### Safety (20)
Is CBD Safe?, Side Effects, Common Side Effects, Rare Side Effects, Can You Overdose?, Drug Interactions, Prescription Medications, Blood Thinners, Antidepressants, Antibiotics, Drug Tests, Is CBD Addictive?, Tolerance, CBD and Alcohol, CBD and Caffeine, Long-Term Safety, Safety for Seniors, Safety During Fasting, Who Should Not Take CBD, Contraindications

#### Quality (20)
What to Look for When Buying, Quality Standards, Third-Party Testing, Understanding COAs, Potency Testing, Contaminant Testing, Heavy Metals, Pesticides, Residual Solvents, Microbial Testing, Organic CBD, GMP Certification, ISO Certification, EU-GMP Standards, Red Flags, Low-Quality CBD, Shelf Life, Check if Real, Source Quality, Batch Testing

---

### CATEGORY 10: COMPARISONS (55 articles)

#### CBD vs Natural Alternatives (20)
CBD vs: Melatonin, Ashwagandha, Valerian, Kratom, Turmeric, Magnesium, L-Theanine, GABA Supplements, 5-HTP, Fish Oil, Passionflower, Chamomile, Lavender, Kava, Rhodiola, Ginkgo Biloba, St. John's Wort, Arnica, Essential Oils, Acupuncture

#### CBD vs Pharmaceuticals (10)
CBD vs: Ibuprofen, NSAIDs, Paracetamol, Prescription Painkillers, Benzodiazepines, SSRIs, Sleeping Pills, Muscle Relaxants, Steroids, Medical Marijuana

#### Product Comparisons (25)
CBD Oil vs Hemp Oil, Hemp Seed Oil, Capsules, Gummies, Cream, Vape, Tincture | Gummies vs Capsules, Oil for Anxiety, Oil for Sleep | Cream vs Balm vs Salve, Oil for Pain | Topical vs Oral | Softgels vs Capsules | Flower vs Oil | Edibles vs Oil, Sublingual | Full Spectrum vs Isolate, for Sleep, for Anxiety | Water Soluble vs Oil | MCT vs Hemp Seed Carrier | High vs Low Potency | With Food vs Empty Stomach | Morning vs Night

---

### CATEGORY 11: LEGAL & REGULATIONS (50 articles)

#### Overview Articles (10)
Is CBD Legal? Global Overview, CBD Laws in Europe, CBD Laws in the EU, Novel Food Regulations, THC Limits, Marketing Claims, Traveling with CBD in Europe, Flying with CBD, Import/Export Laws, Workplace Drug Testing

#### Country-Specific (40)
Is CBD Legal in: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, **Denmark**, Estonia, **Finland**, France, **Germany**, Greece, Hungary, Ireland, **Italy**, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, **Portugal**, Romania, Slovakia, Slovenia, Spain, **Sweden**, **Switzerland**, UK, **Norway**, Iceland, USA, Canada, Australia, New Zealand, Japan, South Korea, Brazil, Mexico, South Africa

*Bold = Markets where we own premium domains*

---

### CATEGORY 12: DEMOGRAPHICS (25 articles)

CBD for: Beginners, First-Time Users, Seniors, Over 50, Over 60, Athletes, Runners, Cyclists, Weightlifters, Yoga Practitioners, Women, Men, Students, Professionals, Shift Workers, Travelers, Vegans, People with Allergies, People Who Don't Like THC, People New to Cannabis, Healthcare Workers, Musicians, Creatives, Parents, Caregivers

---

### CATEGORY 13: HEMP & CULTIVATION (25 articles)

What is Hemp?, Hemp vs Cannabis, Hemp Anatomy, How Hemp is Grown, Organic Hemp Farming, Hemp Farming in Europe, Sustainable Cultivation, Hemp Seed vs Flower, Hemp Strains, High-CBD Strains, Harvesting, Drying and Curing, Processing Methods, Hemp Biomass, EU Approved Varieties, Certification Programs, Hemp and Environment, Carbon Footprint, Sustainability Benefits, Supply Chain, Seed-to-Sale Tracking, Quality Indicators, Sourcing Quality Hemp, European vs American Hemp, Swiss Hemp Quality

---

### CATEGORY 14: FAQ & COMMON QUESTIONS (35 articles)

#### General Questions (15)
Does CBD Work?, Why Doesn't CBD Work for Me?, How Do I Know if CBD is Working?, Can CBD Make You Fail a Drug Test?, Can You Take Too Much?, Can You Drive After?, Can You Work While Taking?, Does CBD Make You Tired?, Hungry?, Cause Dry Mouth?, Cause Headaches?, Does CBD Expire?, Can CBD Go Bad?, Is CBD Worth It?, Is CBD a Scam?

#### Product Questions (10)
What is the Best CBD Product?, How Much Oil Should I Take?, What Strength Should I Buy?, Can I Use Oil on Skin?, Add to Food?, Add to Drinks?, Should I Take Oil or Gummies?, What Does CBD Taste Like?, Why is CBD So Expensive?, Cheapest Way to Take CBD?

#### Safety Questions (10)
Is CBD Safe Every Day?, Safe for Older Adults?, Safe with Medication?, Before Surgery?, While Fasting?, Mix with Supplements?, What Happens if I Stop?, Can I Take Long-Term?, Are There Recalls?, How to Report Side Effects?

---

## 8. RESEARCH INTEGRATION

### 8.1 The Research Advantage

CBD Portal has **698 studies** in its database â€” the largest CBD research collection available publicly. This is a core competitive moat.

### 8.2 Evidence Score System

Every condition article displays an Evidence Score showing research quality:

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  CBD AND ANXIETY                                        â”‚
â”‚                                                         â”‚
â”‚  Evidence Score: â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–‘â–‘ 8/10                       â”‚
â”‚                                                         â”‚
â”‚  Based on: 47 studies                                   â”‚
â”‚  Including: 12 randomized controlled trials             â”‚
â”‚  Total participants: 3,400+                             â”‚
â”‚                                                         â”‚
â”‚  Research Trend: ğŸ“ˆ Increasing                          â”‚
â”‚  (More studies being published in this area)            â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### 8.3 Evidence Score Criteria

| Score | Rating | Criteria |
|-------|--------|----------|
| 9-10 | Strong | Multiple large RCTs, consistent results, meta-analyses |
| 7-8 | Moderate | Several RCTs, mostly positive results |
| 5-6 | Preliminary | Few RCTs, mixed results, mostly observational |
| 3-4 | Limited | Mainly animal studies, very few human trials |
| 1-2 | Insufficient | Only preclinical data, case reports |

### 8.4 "What Research Says" Section Template

Required in all 280 condition articles:

```markdown
## What Research Says

Our research database includes [X] studies examining CBD and [condition]. 
Here's what the current evidence suggests:

**Evidence Score: [X]/10** â€” [Rating description]

**Key Finding 1:** A [year] [study type] published in *[Journal]* examined 
[number] participants. Researchers found [specific finding]. 
[â†’ View study](/research/[study-id])

**Key Finding 2:** Research from [year] reported [finding]. 
[â†’ View study](/research/[study-id])

**What This Means:** The research suggests CBD may [cautious summary]. 
However, [limitation].

**Research Gaps:** More studies are needed to understand [unknown]. 
Most existing research [limitation].

[View all [X] studies on [condition] â†’](/research?condition=[condition])
```

### 8.5 Research Trend Indicators

| Indicator | Meaning |
|-----------|---------|
| ğŸ“ˆ Increasing | More studies being published; growing research interest |
| â¡ï¸ Stable | Consistent research output |
| ğŸ“‰ Declining | Less new research; may be mature or abandoned area |

---

# PART 3: BRAND BENCHMARK SYSTEM

---

## 9. BENCHMARK SCORING METHODOLOGY

### 9.1 Overview

The CBD Portal Benchmark System provides objective, transparent brand evaluation. All brands are evaluated using identical criteria, and no brand can pay for a better score.

### 9.2 Scoring Categories (100 Points Total)

| Category | Points | Weight |
|----------|--------|--------|
| **Product Quality** | 30 | Primary factor |
| **Transparency & Testing** | 25 | Trust essential |
| **Value** | 20 | Consumer priority |
| **Trust & Reputation** | 15 | Track record matters |
| **Customer Experience** | 10 | Service quality |

### 9.3 Detailed Scoring Rubric

#### Product Quality (30 points)

| Criterion | Points | How Measured |
|-----------|--------|--------------|
| Potency Accuracy | 10 | Lab results vs. label claim (Â±10% = full points) |
| Extraction Method | 5 | CO2 = 5, Ethanol = 4, Other = 2, Unknown = 0 |
| Spectrum Quality | 5 | Cannabinoid + terpene diversity |
| Ingredient Quality | 5 | Carrier oil quality, additives assessment |
| Batch Consistency | 5 | Multiple COAs showing consistent quality |

#### Transparency & Testing (25 points)

| Criterion | Points | How Measured |
|-----------|--------|--------------|
| COA Availability | 10 | Easily accessible = 10, On request = 5, None = 0 |
| Third-Party Lab | 5 | ISO 17025 accredited = 5, Other = 3, In-house = 0 |
| Batch-Specific Testing | 5 | Every batch = 5, Random = 3, None = 0 |
| Contaminant Testing | 5 | Full panel = 5, Partial = 3, None = 0 |

#### Value (20 points)

| Criterion | Points | How Measured |
|-----------|--------|--------------|
| Price per mg CBD | 10 | Compared to market average |
| Strength Options | 5 | 3+ options = 5, 2 = 3, 1 = 1 |
| Size Options | 5 | Multiple sizes = 5, Single = 2 |

#### Trust & Reputation (15 points)

| Criterion | Points | How Measured |
|-----------|--------|--------------|
| Company History | 5 | 5+ years = 5, 2-5 = 3, <2 = 1 |
| Certifications | 5 | GMP, Organic, ISO, etc. |
| Customer Reviews | 5 | Aggregated from Trustpilot, Google, etc. |

#### Customer Experience (10 points)

| Criterion | Points | How Measured |
|-----------|--------|--------------|
| Website Quality | 3 | Information clarity, navigation |
| Shipping & Returns | 4 | Policies, speed, coverage |
| Customer Service | 3 | Response time, helpfulness |

### 9.4 Rating Scale

| Score | Rating | Badge | Meaning |
|-------|--------|-------|---------|
| 90-100 | Excellent | â­â­â­â­â­ | Best in class, highly recommended |
| 80-89 | Very Good | â­â­â­â­ | Strong choice, minor areas for improvement |
| 70-79 | Good | â­â­â­ | Solid option, some concerns |
| 60-69 | Fair | â­â­ | Acceptable but significant gaps |
| Below 60 | Poor | â­ | Not recommended |

### 9.5 Visual Score Display

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  FORMULA SWISS                              â­â­â­â­â­     â”‚
â”‚  â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•   â”‚
â”‚                                                         â”‚
â”‚  OVERALL SCORE: 94/100                                  â”‚
â”‚                                                         â”‚
â”‚  Product Quality     â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–‘â–‘  28/30     â”‚
â”‚  Transparency        â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–‘â–‘  24/25     â”‚
â”‚  Value               â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–‘â–‘â–‘â–‘â–‘â–‘  16/20     â”‚
â”‚  Trust & Reputation  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–‘â–‘  14/15     â”‚
â”‚  Customer Experience â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–‘â–‘  10/10     â”‚
â”‚                                                         â”‚
â”‚  âœ“ Swiss Made           âœ“ Organic Certified            â”‚
â”‚  âœ“ ISO 17025 Lab        âœ“ Full Spectrum Available      â”‚
â”‚  âœ“ Batch-Specific COAs  âœ“ 5+ Years in Business         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## 10. BRAND REVIEW PROCESS

### 10.1 Review Workflow

```
1. SELECTION
   â””â”€â”€ Brand meets minimum criteria for review

2. DATA COLLECTION
   â”œâ”€â”€ Purchase products anonymously
   â”œâ”€â”€ Request COAs
   â”œâ”€â”€ Review website and policies
   â””â”€â”€ Collect customer reviews

3. TESTING & EVALUATION
   â”œâ”€â”€ Verify lab reports
   â”œâ”€â”€ Score each criterion
   â””â”€â”€ Document evidence

4. REVIEW WRITING
   â”œâ”€â”€ Apply template
   â”œâ”€â”€ Calculate scores
   â””â”€â”€ Write analysis

5. QUALITY CHECK
   â”œâ”€â”€ Editor review
   â”œâ”€â”€ Fact verification
   â””â”€â”€ Score validation

6. PUBLICATION
   â””â”€â”€ Add to database with full documentation
```

### 10.2 Brand Coverage by Market

| Market | International Brands | Local Brands | Total Target |
|--------|---------------------|--------------|--------------|
| **International EN** | 100 | â€” | 100 |
| **Denmark (CBD.dk)** | 100 | +20-30 Danish | 120-130 |
| **Germany (CBD.de)** | 100 | +40-50 German | 140-150 |

### 10.3 Review Update Policy

| Trigger | Action |
|---------|--------|
| 12 months since last review | Full re-review |
| Significant product change | Partial re-review |
| Company ownership change | Full re-review |
| Customer complaint pattern | Investigation |
| Brand request | Review if valid concern |

### 10.4 Dispute Resolution

Brands may dispute scores through a formal process:

1. Submit dispute with evidence
2. Editorial team reviews
3. Re-testing if warranted
4. Decision published (score adjusted or maintained)
5. Dispute outcome noted on review

---

# PART 4: NEWSLETTER STRATEGY

---

## 11. NEWSLETTER ARCHITECTURE

### 11.1 Newsletter per Market

| Newsletter | Domain | Language | Frequency |
|------------|--------|----------|-----------|
| **CBD Portal Weekly** | [international domain] | English | Weekly |
| **CBD Danmark Ugebrev** | cbd.dk | Danish | Weekly |
| **CBD Deutschland Wochenbrief** | cbd.de | German | Weekly |

### 11.2 Content Structure

| Section | Purpose | Frequency |
|---------|---------|-----------|
| **Research Spotlight** | New study explained simply | Every issue |
| **Education Feature** | Article from knowledge base | Every issue |
| **Market News** | Regulatory updates, industry news | As relevant |
| **Brand Spotlight** | Featured brand review (editorial choice) | Bi-weekly |
| **Tool Tip** | Feature a calculator or tool | Monthly |
| **Reader Questions** | Community engagement | Weekly |
| **Sponsor Message** | Clearly labeled sponsorship | As sold |

### 11.3 Sample Newsletter Template

```
â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”
CBD PORTAL WEEKLY
Issue #XX | [Date]
â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

ğŸ“° THIS WEEK'S HIGHLIGHTS

[Brief overview of what's inside]

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

ğŸ”¬ RESEARCH SPOTLIGHT

[Study title]
[Journal, Year]

[2-3 paragraph plain-English summary]

â†’ Read the full study analysis
â†’ View all [condition] research

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

ğŸ“š FEATURED ARTICLE

[Article title]

[Excerpt]

â†’ Read full article

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

ğŸ“£ SPONSORED BY [BRAND]

[Sponsor message - clearly labeled]

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

ğŸ’¬ READER QUESTION

Q: [Question from subscriber]

A: [Expert answer]

Have a question? Reply to this email.

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

[Footer with unsubscribe, address, etc.]
```

### 11.4 Sponsorship Model

**Sponsorship Tiers:**

| Tier | Placement | Rate (Target) |
|------|-----------|---------------|
| **Primary Sponsor** | Logo in header, dedicated section | â‚¬â‚¬â‚¬ |
| **Section Sponsor** | "Brought to you by" on one section | â‚¬â‚¬ |
| **Mention** | Single line mention | â‚¬ |

**Sponsorship Rules:**
- Maximum 1 primary sponsor per issue
- Sponsors do not influence editorial content
- Sponsored content always clearly labeled
- Sponsors cannot be brands currently under negative review
- Sponsorship does not guarantee positive review

---

## 12. LEAD MAGNETS & GROWTH

### 12.1 Lead Magnets by Market

| Lead Magnet | EN | DA | DE | Format |
|-------------|----|----|-----|--------|
| CBD Beginner's Guide | âœ… | âœ… | âœ… | PDF |
| Complete Dosage Guide | âœ… | âœ… | âœ… | PDF |
| Drug Interaction Checklist | âœ… | âœ… | âœ… | PDF |
| Country Legal Guide | Int'l | Denmark | Germany | PDF |
| Pet CBD Guide | âœ… | âœ… | âœ… | PDF |
| Brand Comparison Report | âœ… | âœ… | âœ… | PDF |
| Calculator Results | âœ… | âœ… | âœ… | Email |
| Quiz Results | âœ… | âœ… | âœ… | Email |

### 12.2 Capture Points

| Location | Method | Lead Magnet Offered |
|----------|--------|---------------------|
| **Article Footer** | Inline form | Related guide |
| **Sidebar** | Sticky form | Beginner's Guide |
| **Exit Intent** | Popup | Best guide for page topic |
| **Tool Results** | "Email my results" | Calculator output |
| **Quiz Completion** | Required for results | Product recommendations |
| **Homepage** | Hero section CTA | Beginner's Guide |
| **Landing Pages** | Dedicated pages | Specific lead magnets |

### 12.3 Growth Targets

| Milestone | Subscribers | Timeline |
|-----------|-------------|----------|
| Launch | 0 | Day 1 |
| Early | 1,000 | Month 3 |
| Growth | 5,000 | Month 6 |
| Established | 15,000 | Month 12 |
| Scale | 50,000+ | Year 2+ |

*Targets are per newsletter (EN, DA, DE separate)*

### 12.4 Email Platform Requirements

| Feature | Required |
|---------|----------|
| Multi-list management | Yes (per market) |
| Automation sequences | Yes |
| Segmentation | Yes |
| A/B testing | Yes |
| GDPR compliance | Essential |
| Multi-language support | Yes |
| Analytics | Yes |

**Recommended platforms:** ConvertKit, Beehiiv, or Mailchimp

---

# PART 5: WRITING & PRODUCTION

---

## 13. BRAND VOICE & TONE

### 13.1 Core Positioning

CBD Portal is the **research-backed, independent** CBD information resource. We educate consumers with evidence, not marketing claims.

### 13.2 Voice Attributes

| Attribute | Description | Example |
|-----------|-------------|---------|
| **Authoritative** | Confident but not arrogant | "Research suggests..." not "CBD definitely..." |
| **Educational** | Teaching, not selling | Explain concepts, don't push products |
| **Accessible** | Expert content for non-experts | Define terms, avoid jargon |
| **Honest** | Acknowledge limitations | "More research is needed" when true |
| **Independent** | No brand favoritism | Equal treatment in all content |
| **European** | EU/UK focused | Reference EU regulations, metric units |

### 13.3 Language Rules

**Approved Medical Language:**
- "Research suggests..."
- "Studies indicate..."
- "May help with..."
- "Some people report..."
- "Evidence shows..."
- "Has been associated with..."

**Prohibited Language:**
- "CBD cures..."
- "CBD treats..."
- "Proven to..."
- "Guaranteed to..."
- "Will definitely..."
- "We recommend [brand]..."
- "The best CBD is..."

### 13.4 European Standards

**Use:**
- Metric measurements (mg, ml)
- EUR for price examples
- EU regulations (Novel Food, 0.2% THC)
- European brand examples

**Avoid:**
- FDA references (except for Epidiolex)
- Farm Bill 2018 references
- US state laws (except in US legal article)
- Imperial measurements

---

## 14. ARTICLE TEMPLATES

### 14.1 Standard Article Template (1,500-2,500 words)

```markdown
# [Title with Primary Keyword]

<quick-answer>
[40-60 word featured snippet answer. Direct, no hedging.]
</quick-answer>

<key-takeaways>
- [Key point 1]
- [Key point 2]
- [Key point 3]
- [Key point 4]
- [Key point 5]
</key-takeaways>

<metadata>
- Last Updated: [Date]
- Reviewed By: [Name, Credentials]
- Reading Time: [X] minutes
- Evidence Score: [X/10] (for condition articles)
</metadata>

## Introduction
[100-150 words. Hook, state coverage, primary keyword in first 100 words.]

## [Main Section H2]
[Content with glossary links on first mention of terms.]

## What Research Says
[Required for condition articles. Include Evidence Score, study citations, 
link to research database.]

## How to [Practical Application]
[Actionable guidance with tool links.]

## Safety Considerations
[Side effects, interactions, who should avoid.]

## Frequently Asked Questions

### [PAA Question 1]?
[2-3 sentence answer]

### [PAA Question 2]?
[2-3 sentence answer]

### [PAA Question 3]?
[2-3 sentence answer]

### [PAA Question 4]?
[2-3 sentence answer]

## Conclusion
[80-100 words. Summary + next steps with internal links.]

---

## Sources
1. [Citation with link to research database]
2. [Citation]

---

<disclaimer>
**Medical Disclaimer:** This article is for informational purposes only 
and does not constitute medical advice. Consult a healthcare professional 
before using CBD.
</disclaimer>
```

### 14.2 Brand Review Template

```markdown
# [Brand Name] Review [Year]

<quick-answer>
[Brand Name] scores [XX/100] in our independent benchmark. 
[1-sentence summary of strengths/weaknesses].
</quick-answer>

<score-card>
Overall: XX/100 | â­â­â­â­â­
- Product Quality: XX/30
- Transparency: XX/25
- Value: XX/20
- Trust: XX/15
- Experience: XX/10
</score-card>

<metadata>
- Last Reviewed: [Date]
- Reviewed By: [Name]
- Products Tested: [X]
- Methodology: [Link to methodology page]
</metadata>

## Overview
[Company background, products offered, market presence]

## Product Quality (XX/30)
[Detailed assessment with evidence]

## Transparency & Testing (XX/25)
[COA availability, lab details, contaminant testing]

## Value (XX/20)
[Price per mg analysis, comparison to market]

## Trust & Reputation (XX/15)
[Company history, certifications, customer reviews]

## Customer Experience (XX/10)
[Website, shipping, service assessment]

## Products Tested
[List of specific products reviewed]

## Pros and Cons

**Pros:**
- [Pro 1]
- [Pro 2]
- [Pro 3]

**Cons:**
- [Con 1]
- [Con 2]

## Best For
[Who this brand is ideal for]

## Verdict
[Summary conclusion]

---

<methodology-note>
This review follows CBD Portal's published benchmark methodology. 
All brands are evaluated using identical criteria. 
[View full methodology â†’](/methodology)
</methodology-note>
```

---

## 15. SEO REQUIREMENTS

### 15.1 On-Page Checklist

| Element | Requirement |
|---------|-------------|
| **Title Tag** | 50-60 characters, keyword near front |
| **Meta Description** | 140-155 characters, compelling |
| **H1** | One per page, includes primary keyword |
| **URL Slug** | Lowercase, hyphens, 3-5 words |
| **H2s** | 4-8 per article, include secondary keywords |
| **Primary Keyword** | In first 100 words, H1, title, meta, URL |
| **Internal Links** | 5+ per article |
| **External Links** | To research database (not external sites) |
| **Images** | 1+ with descriptive alt text |
| **Word Count** | 1,500+ (standard), 3,000+ (pillar) |

### 15.2 Schema Markup

| Content Type | Schema Required |
|--------------|-----------------|
| All articles | Article, BreadcrumbList, WebPage |
| Condition articles | + FAQPage, MedicalWebPage |
| How-to articles | + FAQPage, HowTo |
| Brand reviews | + Review, Organization |
| Tools | + WebApplication |

### 15.3 Featured Snippet Optimization

| Query Type | Format | Example |
|------------|--------|---------|
| "What is X?" | Definition (40-50 words, bold term) | What is CBD? |
| "X vs Y" | Comparison table (5-7 rows) | CBD vs THC |
| "How to X" | Numbered list (5-8 steps) | How to take CBD |
| "Best X for Y" | Bulleted list | Best CBD for anxiety |
| "Does X help Y?" | Paragraph (40-60 words) | Does CBD help anxiety? |

---

## 16. QUALITY CHECKLIST

### Pre-Publication Checklist

**Content Quality:**
- [ ] Quick Answer present (40-60 words)
- [ ] Key Takeaways (3-5 bullets)
- [ ] What Research Says section (condition articles)
- [ ] Evidence Score displayed (condition articles)
- [ ] FAQ section (4-6 questions)
- [ ] Conclusion with next steps
- [ ] Sources listed
- [ ] Disclaimer present

**SEO:**
- [ ] Title tag 50-60 characters
- [ ] Meta description 140-155 characters
- [ ] Primary keyword in first 100 words
- [ ] URL slug optimized
- [ ] Schema markup applied

**Internal Linking:**
- [ ] Links to pillar article
- [ ] 3-5 same-category links
- [ ] 2-3 cross-category links
- [ ] Glossary terms linked (first mention)
- [ ] Tool links included
- [ ] Research database links included

**Writing Quality:**
- [ ] Flesch-Kincaid Grade 8 or lower
- [ ] No medical claims
- [ ] No brand favoritism
- [ ] European focus
- [ ] Metric measurements

**Formatting:**
- [ ] H2s every 200-300 words
- [ ] Paragraphs 2-4 sentences
- [ ] Tables for comparisons
- [ ] Proper heading hierarchy

---

# PART 6: TECHNICAL ARCHITECTURE

---

## 21. UNIFIED BACKEND SYSTEM

### 21.1 Architecture Overview

Single backend database serving all markets with a translation layer:

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                    UNIFIED BACKEND                          â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”‚
â”‚  â”‚                 SUPABASE DATABASE                    â”‚   â”‚
â”‚  â”‚                                                      â”‚   â”‚
â”‚  â”‚  SOURCE CONTENT (English = Source of Truth)         â”‚   â”‚
â”‚  â”‚  â”œâ”€â”€ articles                                        â”‚   â”‚
â”‚  â”‚  â”œâ”€â”€ brands                                          â”‚   â”‚
â”‚  â”‚  â”œâ”€â”€ brand_reviews                                   â”‚   â”‚
â”‚  â”‚  â””â”€â”€ tools_config                                    â”‚   â”‚
â”‚  â”‚                                                      â”‚   â”‚
â”‚  â”‚  TRANSLATIONS (Linked to Source)                    â”‚   â”‚
â”‚  â”‚  â”œâ”€â”€ article_translations                           â”‚   â”‚
â”‚  â”‚  â”œâ”€â”€ review_translations                            â”‚   â”‚
â”‚  â”‚  â”œâ”€â”€ glossary_translations                          â”‚   â”‚
â”‚  â”‚  â””â”€â”€ ui_translations                                â”‚   â”‚
â”‚  â”‚                                                      â”‚   â”‚
â”‚  â”‚  SHARED DATA (Language-Independent)                 â”‚   â”‚
â”‚  â”‚  â”œâ”€â”€ research_studies (698)                         â”‚   â”‚
â”‚  â”‚  â”œâ”€â”€ glossary_terms (251)                           â”‚   â”‚
â”‚  â”‚  â”œâ”€â”€ brand_scores                                   â”‚   â”‚
â”‚  â”‚  â””â”€â”€ analytics                                      â”‚   â”‚
â”‚  â”‚                                                      â”‚   â”‚
â”‚  â”‚  COMMUNITY                                          â”‚   â”‚
â”‚  â”‚  â”œâ”€â”€ comments                                       â”‚   â”‚
â”‚  â”‚  â”œâ”€â”€ comment_moderation                             â”‚   â”‚
â”‚  â”‚  â””â”€â”€ user_profiles                                  â”‚   â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                              â”‚
                              â”‚ API Layer
                              â”‚
        â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
        â–¼                     â–¼                     â–¼
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”    â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”    â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ FRONTEND     â”‚    â”‚ FRONTEND     â”‚    â”‚ FRONTEND     â”‚
â”‚ Internationalâ”‚    â”‚   cbd.dk     â”‚    â”‚   cbd.de     â”‚
â”‚   English    â”‚    â”‚   Danish     â”‚    â”‚   German     â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜    â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜    â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### 21.2 Benefits of Unified Backend

| Benefit | Description |
|---------|-------------|
| **Single source of truth** | English content is authoritative |
| **Efficient updates** | Update once, sync to all languages |
| **Consistency** | Same data structure across markets |
| **Translation tracking** | Know what's translated, what's outdated |
| **Scalability** | Add new languages without new databases |
| **Shared assets** | Research, glossary, brands shared |

### 21.3 Codebase Structure

```
/cbd-portal (Monorepo)
â”œâ”€â”€ /apps
â”‚   â”œâ”€â”€ /international    â†’ [international-domain.com]
â”‚   â”œâ”€â”€ /denmark          â†’ cbd.dk
â”‚   â””â”€â”€ /germany          â†’ cbd.de
â”œâ”€â”€ /packages
â”‚   â”œâ”€â”€ /ui               â†’ Shared React components
â”‚   â”œâ”€â”€ /database         â†’ Supabase client & queries
â”‚   â”œâ”€â”€ /content          â†’ Content utilities
â”‚   â””â”€â”€ /i18n             â†’ Translation system
â”œâ”€â”€ /locales
â”‚   â”œâ”€â”€ /en               â†’ English UI translations
â”‚   â”œâ”€â”€ /da               â†’ Danish UI translations
â”‚   â””â”€â”€ /de               â†’ German UI translations
â””â”€â”€ /public
    â””â”€â”€ /shared           â†’ Shared assets (images, icons)
```

---

## 22. DATABASE SCHEMA

### 22.1 Articles (Source Content)

```sql
CREATE TABLE articles (
  id UUID PRIMARY KEY DEFAULT uuid_generate_v4(),
  
  -- Identifiers
  slug VARCHAR(255) UNIQUE NOT NULL,
  
  -- Content
  title VARCHAR(255) NOT NULL,
  meta_description VARCHAR(160),
  content TEXT NOT NULL,
  excerpt TEXT,
  
  -- Structure
  category VARCHAR(100) NOT NULL,
  subcategory VARCHAR(100),
  content_type VARCHAR(50), -- pillar, comprehensive, standard, quick_answer
  word_count INTEGER,
  
  -- SEO
  primary_keyword VARCHAR(255),
  secondary_keywords TEXT[],
  
  -- Research integration
  evidence_score DECIMAL(3,1), -- 1.0 to 10.0
  related_studies UUID[],
  
  -- Status
  status VARCHAR(20) DEFAULT 'draft', -- draft, review, approved, published
  published_at TIMESTAMP,
  updated_at TIMESTAMP DEFAULT NOW(),
  
  -- Authorship
  author_id UUID REFERENCES users(id),
  reviewer_id UUID REFERENCES users(id),
  
  -- Translation tracking
  needs_translation BOOLEAN DEFAULT TRUE,
  source_updated_at TIMESTAMP
);

CREATE INDEX idx_articles_category ON articles(category);
CREATE INDEX idx_articles_status ON articles(status);
CREATE INDEX idx_articles_slug ON articles(slug);
```

### 22.2 Article Translations

```sql
CREATE TABLE article_translations (
  id UUID PRIMARY KEY DEFAULT uuid_generate_v4(),
  
  -- Link to source
  article_id UUID REFERENCES articles(id) ON DELETE CASCADE,
  language VARCHAR(5) NOT NULL, -- da, de, fr, etc.
  
  -- Translated content
  slug VARCHAR(255) NOT NULL,
  title VARCHAR(255) NOT NULL,
  meta_description VARCHAR(160),
  content TEXT NOT NULL,
  excerpt TEXT,
  
  -- Status
  status VARCHAR(20) DEFAULT 'draft', -- draft, pending_review, approved, published
  translation_method VARCHAR(20), -- ai_draft, human, ai_reviewed
  
  -- Workflow
  translator_id UUID REFERENCES users(id),
  reviewer_id UUID REFERENCES users(id),
  translated_at TIMESTAMP,
  reviewed_at TIMESTAMP,
  published_at TIMESTAMP,
  
  -- Sync tracking
  source_version_at TIMESTAMP,
  needs_update BOOLEAN DEFAULT FALSE,
  
  UNIQUE(article_id, language)
);

CREATE INDEX idx_translations_article ON article_translations(article_id);
CREATE INDEX idx_translations_language ON article_translations(language);
CREATE INDEX idx_translations_status ON article_translations(status);
CREATE INDEX idx_translations_needs_update ON article_translations(needs_update) 
  WHERE needs_update = TRUE;
```

### 22.3 Comments

```sql
CREATE TABLE comments (
  id UUID PRIMARY KEY DEFAULT uuid_generate_v4(),
  
  -- What it's on
  article_id UUID REFERENCES articles(id) ON DELETE CASCADE,
  language VARCHAR(5) NOT NULL,
  
  -- Threading
  parent_id UUID REFERENCES comments(id) ON DELETE CASCADE,
  thread_depth INTEGER DEFAULT 0,
  
  -- Author info
  author_name VARCHAR(100) NOT NULL,
  author_email VARCHAR(255) NOT NULL,
  author_website VARCHAR(255),
  author_ip INET,
  
  -- Content
  content TEXT NOT NULL,
  content_html TEXT,
  
  -- Moderation
  status VARCHAR(20) DEFAULT 'pending', -- pending, approved, rejected, spam
  moderated_by UUID REFERENCES users(id),
  moderated_at TIMESTAMP,
  rejection_reason TEXT,
  
  -- Spam detection
  spam_score DECIMAL(3,2),
  spam_signals JSONB,
  
  -- Engagement
  helpful_votes INTEGER DEFAULT 0,
  unhelpful_votes INTEGER DEFAULT 0,
  is_flagged BOOLEAN DEFAULT FALSE,
  flag_count INTEGER DEFAULT 0,
  
  -- Timestamps
  created_at TIMESTAMP DEFAULT NOW(),
  updated_at TIMESTAMP,
  
  -- Edit tracking
  is_edited BOOLEAN DEFAULT FALSE,
  edit_window_expires_at TIMESTAMP
);

CREATE INDEX idx_comments_article ON comments(article_id);
CREATE INDEX idx_comments_status ON comments(status);
CREATE INDEX idx_comments_pending ON comments(status) WHERE status = 'pending';
```

### 22.4 Translation Jobs

```sql
CREATE TABLE translation_jobs (
  id UUID PRIMARY KEY DEFAULT uuid_generate_v4(),
  
  -- What to translate
  content_type VARCHAR(50) NOT NULL, -- article, review, glossary
  content_id UUID NOT NULL,
  target_language VARCHAR(5) NOT NULL,
  
  -- Status
  status VARCHAR(20) DEFAULT 'queued', -- queued, ai_draft, pending_human, in_review, complete
  priority INTEGER DEFAULT 5, -- 1 = highest
  
  -- AI draft
  ai_draft_content TEXT,
  ai_drafted_at TIMESTAMP,
  ai_model_used VARCHAR(50),
  
  -- Human translation
  translator_id UUID REFERENCES users(id),
  assigned_at TIMESTAMP,
  human_content TEXT,
  completed_at TIMESTAMP,
  
  -- Review
  reviewer_id UUID REFERENCES users(id),
  review_started_at TIMESTAMP,
  review_completed_at TIMESTAMP,
  review_notes TEXT,
  
  created_at TIMESTAMP DEFAULT NOW(),
  updated_at TIMESTAMP DEFAULT NOW()
);
```

### 22.5 Translation Memory

```sql
CREATE TABLE translation_memory (
  id UUID PRIMARY KEY DEFAULT uuid_generate_v4(),
  source_language VARCHAR(5) DEFAULT 'en',
  target_language VARCHAR(5) NOT NULL,
  source_text TEXT NOT NULL,
  translated_text TEXT NOT NULL,
  context VARCHAR(100),
  confidence DECIMAL(3,2),
  created_at TIMESTAMP DEFAULT NOW(),
  source_text_hash VARCHAR(64) -- for exact match lookup
);
```

---

## 23. TRANSLATION SYSTEM

### 23.1 Translation Workflow

```
TRANSLATION WORKFLOW

1. ARTICLE PUBLISHED (English)
   â””â”€â”€ Triggers: Create translation_jobs for DA, DE

2. AI DRAFT GENERATION
   â”œâ”€â”€ Pull article content
   â”œâ”€â”€ Query translation_memory for known phrases
   â”œâ”€â”€ Generate AI translation (Claude API)
   â”œâ”€â”€ Store as ai_draft_content
   â””â”€â”€ Status â†’ ai_draft

3. HUMAN REVIEW QUEUE
   â”œâ”€â”€ Translator claims job from queue
   â”œâ”€â”€ Sees: English source + AI draft side-by-side
   â”œâ”€â”€ Edits AI draft (typically 20-30% changes)
   â”œâ”€â”€ Marks complete
   â””â”€â”€ Status â†’ pending_review

4. EDITOR REVIEW
   â”œâ”€â”€ Reviewer checks translation quality
   â”œâ”€â”€ Checks: Medical accuracy, brand voice, local relevance
   â”œâ”€â”€ Approves or returns with notes
   â””â”€â”€ Status â†’ complete

5. PUBLISH
   â”œâ”€â”€ Create article_translation record
   â”œâ”€â”€ Status â†’ published
   â””â”€â”€ Update translation_memory with confirmed translations

6. SYNC CHECK (Ongoing)
   â”œâ”€â”€ When English source updated
   â”œâ”€â”€ Flag translations as needs_update
   â”œâ”€â”€ Create new translation_jobs
   â””â”€â”€ Show "being updated" notice on site
```

### 23.2 Translation Interface

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ TRANSLATION: CBD and Anxiety â†’ Danish                       â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                             â”‚
â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”    â”‚
â”‚ â”‚ ENGLISH (Source)        â”‚ â”‚ DANISH (Translation)    â”‚    â”‚
â”‚ â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤ â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤    â”‚
â”‚ â”‚                         â”‚ â”‚                         â”‚    â”‚
â”‚ â”‚ # CBD and Anxiety       â”‚ â”‚ # CBD og Angst          â”‚    â”‚
â”‚ â”‚                         â”‚ â”‚                         â”‚    â”‚
â”‚ â”‚ CBD has shown promise   â”‚ â”‚ CBD har vist lovende    â”‚    â”‚
â”‚ â”‚ in helping manage       â”‚ â”‚ resultater i at hjÃ¦lpe  â”‚    â”‚
â”‚ â”‚ anxiety symptoms...     â”‚ â”‚ med at hÃ¥ndtere angst...â”‚    â”‚
â”‚ â”‚                         â”‚ â”‚                         â”‚    â”‚
â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜    â”‚
â”‚                                                             â”‚
â”‚ Translation Memory Suggestions:                             â”‚
â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”â”‚
â”‚ â”‚ "endocannabinoid system" â†’ "endocannabinoidsystemet"   â”‚â”‚
â”‚ â”‚ "research suggests" â†’ "forskning tyder pÃ¥"              â”‚â”‚
â”‚ â”‚ "side effects" â†’ "bivirkninger"                         â”‚â”‚
â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜â”‚
â”‚                                                             â”‚
â”‚ [Save Draft] [Mark Complete] [Request Review]              â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### 23.3 UI Translations (i18n)

```typescript
// /locales/en.json
{
  "common": {
    "read_more": "Read more",
    "share": "Share",
    "comments": "Comments",
    "search": "Search"
  },
  "article": {
    "evidence_score": "Evidence Score",
    "based_on_studies": "Based on {{count}} studies",
    "last_updated": "Last updated",
    "reviewed_by": "Reviewed by"
  }
}

// /locales/da.json
{
  "common": {
    "read_more": "LÃ¦s mere",
    "share": "Del",
    "comments": "Kommentarer",
    "search": "SÃ¸g"
  },
  "article": {
    "evidence_score": "Evidensscore",
    "based_on_studies": "Baseret pÃ¥ {{count}} studier",
    "last_updated": "Sidst opdateret",
    "reviewed_by": "GennemgÃ¥et af"
  }
}

// /locales/de.json
{
  "common": {
    "read_more": "Mehr lesen",
    "share": "Teilen",
    "comments": "Kommentare",
    "search": "Suchen"
  },
  "article": {
    "evidence_score": "Evidenzbewertung",
    "based_on_studies": "Basierend auf {{count}} Studien",
    "last_updated": "Zuletzt aktualisiert",
    "reviewed_by": "ÃœberprÃ¼ft von"
  }
}
```

---

## 24. COMMENT SYSTEM

### 24.1 Comment Features

| Feature | Description |
|---------|-------------|
| **Threaded replies** | One level deep (reply to comment, not reply to reply) |
| **Moderation queue** | All comments pending until approved |
| **Author badges** | "CBD Portal Team" badge for staff |
| **Edit window** | 15 minutes to edit after posting |
| **Voting** | Helpful / Not helpful |
| **Flagging** | Report spam, offensive, misinformation |
| **Email notifications** | Optional notify on reply |

### 24.2 Comment Submission Flow

```
USER SUBMITS COMMENT
        â”‚
        â–¼
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ SPAM CHECK        â”‚
â”‚ â”œâ”€â”€ Honeypot      â”‚
â”‚ â”œâ”€â”€ Rate limit    â”‚
â”‚ â”œâ”€â”€ Link count    â”‚
â”‚ â”œâ”€â”€ Akismet API   â”‚
â”‚ â””â”€â”€ Keyword filterâ”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
        â”‚
        â”œâ”€â”€ Spam score > 0.8 â”€â”€â†’ AUTO-REJECT (silent)
        â”‚
        â”œâ”€â”€ Spam score > 0.5 â”€â”€â†’ FLAGGED for review
        â”‚
        â–¼
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ PENDING QUEUE     â”‚
â”‚                   â”‚
â”‚ Notification to:  â”‚
â”‚ - Article author  â”‚
â”‚ - Moderator team  â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
        â”‚
        â–¼
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ MODERATOR ACTION  â”‚
â”‚                   â”‚
â”‚ â”œâ”€â”€ Approve       â”‚â”€â”€â†’ PUBLISHED + notify commenter
â”‚ â”œâ”€â”€ Edit+Approve  â”‚â”€â”€â†’ PUBLISHED (edited)
â”‚ â”œâ”€â”€ Reject        â”‚â”€â”€â†’ HIDDEN + reason logged
â”‚ â””â”€â”€ Spam          â”‚â”€â”€â†’ DELETED + train spam filter
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### 24.3 Moderation Dashboard

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ PENDING COMMENTS (23)                          [Filter â–¼]  â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                             â”‚
â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”â”‚
â”‚ â”‚ On: CBD and Anxiety                                     â”‚â”‚
â”‚ â”‚ From: Maria S. (maria@email.com) â€¢ 10 min ago          â”‚â”‚
â”‚ â”‚ IP: 192.168.1.1 â€¢ First comment: Yes                   â”‚â”‚
â”‚ â”‚ Spam score: 0.12 âœ“                                      â”‚â”‚
â”‚ â”‚                                                         â”‚â”‚
â”‚ â”‚ "I've been using CBD for my anxiety for 3 months now.  â”‚â”‚
â”‚ â”‚ Started with 25mg and now take 50mg. The research you  â”‚â”‚
â”‚ â”‚ cited about serotonin receptors matches my experience."â”‚â”‚
â”‚ â”‚                                                         â”‚â”‚
â”‚ â”‚ [âœ“ Approve] [âœ Edit] [âœ— Reject] [âš‘ Spam]              â”‚â”‚
â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜â”‚
â”‚                                                             â”‚
â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”â”‚
â”‚ â”‚ On: Best CBD Oil Guide                                  â”‚â”‚
â”‚ â”‚ From: John (john@suspicious.xyz) â€¢ 25 min ago          â”‚â”‚
â”‚ â”‚ Spam score: 0.67 âš ï¸                                     â”‚â”‚
â”‚ â”‚                                                         â”‚â”‚
â”‚ â”‚ "Great article! Check out my site for more info        â”‚â”‚
â”‚ â”‚ www.buycheapcbd.com we have the best prices..."        â”‚â”‚
â”‚ â”‚                                                         â”‚â”‚
â”‚ â”‚ [âœ“ Approve] [âœ Edit] [âœ— Reject] [âš‘ Spam]              â”‚â”‚
â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### 24.4 Anti-Spam Measures

| Measure | Implementation |
|---------|----------------|
| **Honeypot field** | Hidden field bots fill, humans don't |
| **Rate limiting** | Max 3 comments per hour per IP |
| **Link limit** | Max 2 links per comment |
| **Akismet** | External spam detection API |
| **Keyword filter** | Block known spam phrases |
| **New commenter flag** | Extra scrutiny for first-time |
| **CAPTCHA** | Only if spam signals detected |

### 24.5 Comment Display

```html
<div class="comment" id="comment-123">
  <div class="comment-header">
    <span class="comment-author">Maria S.</span>
    <span class="comment-date">January 10, 2026</span>
  </div>
  
  <div class="comment-content">
    <p>I've been using CBD for my anxiety for 3 months...</p>
  </div>
  
  <div class="comment-actions">
    <button class="vote-helpful">ğŸ‘ Helpful (12)</button>
    <button class="vote-unhelpful">ğŸ‘ (2)</button>
    <button class="reply-button">Reply</button>
    <button class="flag-button">Report</button>
  </div>
  
  <!-- Staff reply -->
  <div class="comment-replies">
    <div class="comment reply">
      <div class="comment-header">
        <span class="comment-author">
          Dr. Sarah Chen
          <span class="badge badge-team">CBD Portal Team</span>
        </span>
      </div>
      <div class="comment-content">
        <p>Thanks for sharing your experience, Maria!</p>
      </div>
    </div>
  </div>
</div>
```

### 24.6 SEO Benefits of Comments

| Benefit | Mechanism |
|---------|-----------|
| **Fresh content signals** | Comments add new content regularly |
| **Long-tail keywords** | Users ask questions in natural language |
| **Engagement metrics** | More time on page, lower bounce rate |
| **Social proof** | Comments show active community |
| **User-generated content** | Unique content Google values |

---

## 25. TOOLS STRATEGY

### 25.1 Current Tools

| Tool | URL | Status |
|------|-----|--------|
| CBD Dosage Calculator | /tools/dosage-calculator | âœ… Live |
| Animal Dosage Calculator | /tools/animal-dosage-calculator | âœ… Live |

### 25.2 Planned Tools

| Tool | Purpose | Priority | Links From |
|------|---------|----------|------------|
| **Drug Interaction Checker** | CBD + medication safety | HIGH | 300+ articles |
| **CBD Strength Calculator** | Convert mg/ml, percentages | HIGH | 100+ articles |
| **Cost Per mg Calculator** | Compare product value | MEDIUM | 50+ articles |
| **Interactive Legal Map** | CBD legality by country | MEDIUM | 50 articles |
| **Research Finder** | Search 698 studies | MEDIUM | 280 articles |
| **Product Finder Quiz** | Guided recommendations | MEDIUM | Beginner articles |
| **Brand Comparison Tool** | Side-by-side comparison | LOW | Review articles |

### 25.3 Tool Requirements

All tools must:
- Work in all three languages (EN, DA, DE)
- Be mobile responsive
- Include email capture option ("Email my results")
- Link to relevant articles
- Include appropriate disclaimers
- Use shared database for consistency

---

## 26. INTERNAL LINKING

### 26.1 Linking Requirements

| Link Type | Minimum per Article |
|-----------|---------------------|
| Pillar article | 1 |
| Same-category articles | 3-5 |
| Cross-category articles | 2-3 |
| Glossary terms | 3-5 (first mention only) |
| Tools | 1-2 (where relevant) |
| Research database | 1-2 (condition articles) |
| Brand reviews | 0-1 (not pushy) |

### 26.2 Cross-Category Linking Map

| From | Link To |
|------|---------|
| Conditions | Guides (dosage), Tools, Research |
| Products | Conditions, Safety, Comparisons |
| Guides | Products, Tools, Conditions |
| Science | Conditions, Glossary, Research |
| Terpenes | Conditions, Products |
| Legal | Guides (buying), Country-specific |
| Pets | Tools (animal calculator), Safety |

### 26.3 Anchor Text Guidelines

| Link Type | Anchor Style | Example |
|-----------|--------------|---------|
| Exact match | Primary keyword | "CBD for anxiety" |
| Partial match | Variation | "managing anxiety with CBD" |
| Natural | Conversational | "learn more about dosing" |
| Glossary | Term name | "endocannabinoid system" |

---

# PART 7: LAUNCH & OPERATIONS

---

## 27. LAUNCH CRITERIA & PHASES

### 27.1 Phase 1 Complete Criteria (English)

| Criterion | Target | Required |
|-----------|--------|----------|
| Core articles published | 200+ | âœ… Yes |
| Brand reviews complete | 50+ | âœ… Yes |
| Research database integrated | 698 studies | âœ… Yes |
| Tools functional | 3+ | âœ… Yes |
| Newsletter launched | Active | âœ… Yes |
| International domain live | Configured | âœ… Yes |
| Expert team pages | Published | âœ… Yes |
| Legal pages | Complete | âœ… Yes |

### 27.2 Phase 2 Trigger (Danish)

| Criterion | Target |
|-----------|--------|
| Phase 1 complete | âœ… |
| Danish translation workflow tested | Working |
| Danish brand list identified | 20+ brands |
| cbd.dk DNS configured | Ready |
| Danish newsletter setup | Ready |

### 27.3 Phase 3 Trigger (German)

| Criterion | Target |
|-----------|--------|
| Phase 2 launched and stable | 2+ weeks |
| German translation workflow tested | Working |
| German brand list identified | 40+ brands |
| cbd.de DNS configured | Ready |
| German newsletter setup | Ready |

---

## 28. PUBLICATION TIMELINE

### 28.1 Phase 1 Schedule (English)

| Period | Articles | Daily Rate | Focus |
|--------|----------|------------|-------|
| Weeks 1-2 | 50 | 3-5/day | Foundations, core cannabinoids |
| Weeks 3-4 | 100 | 7-8/day | Guides, safety, science |
| Weeks 5-8 | 300 | 10-12/day | Conditions |
| Weeks 9-12 | 400 | 12-15/day | Pets, comparisons, legal, FAQ |
| **Total** | **850** | | **12 weeks** |

### 28.2 Publishing Best Practices

| Practice | Implementation |
|----------|----------------|
| Randomize times | 06:00-22:00 UTC |
| Mix categories | Don't publish 10 similar articles in a row |
| Pillar first | Publish pillar before its clusters |
| Link immediately | Update existing articles with links |
| Stagger similar | Space related articles 2-3 days |

---

## 29. SUCCESS METRICS

### 29.1 Traffic KPIs

| Metric | Month 3 | Month 6 | Month 12 |
|--------|---------|---------|----------|
| Monthly visitors (EN) | 10K | 50K | 200K |
| Monthly visitors (DA) | â€” | 5K | 20K |
| Monthly visitors (DE) | â€” | â€” | 50K |

### 29.2 Content KPIs

| Metric | Target |
|--------|--------|
| Articles ranking page 1 | 20% within 6 months |
| Featured snippets captured | 50+ |
| Average time on page | 3+ minutes |
| Pages per session | 2.5+ |

### 29.3 Newsletter KPIs

| Metric | Target |
|--------|--------|
| Open rate | 35%+ |
| Click rate | 5%+ |
| List growth rate | 10%/month |
| Unsubscribe rate | <1% |

### 29.4 Brand Review KPIs

| Metric | Target |
|--------|--------|
| Reviews completed (EN) | 100 |
| Reviews completed (DA) | +25 local |
| Reviews completed (DE) | +50 local |
| Average review completeness | 90%+ |

---

# APPENDICES

---

## APPENDIX A: E-E-A-T STRATEGY

### Author & Review System

| Element | Implementation |
|---------|----------------|
| Author bylines | Real names with credentials |
| Author pages | Full bio, photo, credentials, articles |
| Medical review | Named reviewer on health content |
| Last updated | Visible timestamp on all articles |
| Editorial policy | Published page explaining standards |
| Methodology | Published benchmark methodology |

### Trust Signals

- Independence statement on every page
- No affiliate disclosure (because none exist)
- Sources section on every article
- Research citations to internal database
- Expert credentials prominently displayed
- Contact information visible

---

## APPENDIX B: LOCALIZATION GUIDELINES

### Translation vs. Localization

| Element | Translate | Localize |
|---------|-----------|----------|
| Core educational content | âœ… | |
| Medical/scientific facts | âœ… | |
| Legal information | | âœ… (country-specific) |
| Brand examples | | âœ… (local brands) |
| Cultural references | | âœ… |
| Regulatory references | | âœ… |
| Expert quotes | | âœ… (add local experts) |
| Pricing examples | | âœ… (local currency) |

### Market-Specific Requirements

**Denmark (CBD.dk):**
- Danish healthcare system context
- Danish regulatory framework
- Danish brand prominence
- Danish expert sources

**Germany (CBD.de):**
- German Novel Food status
- German pharmacy context
- German regulatory complexity
- German brand prominence
- German expert sources

---

## APPENDIX C: LEGAL & COMPLIANCE

### Required Disclaimers

**Medical Disclaimer (all health content):**
```
This article is for informational purposes only and does not constitute 
medical advice. Consult a healthcare professional before using CBD, 
especially if you have a medical condition or take medications.
```

**Legal Disclaimer (legal content):**
```
Laws regarding CBD vary by jurisdiction and change frequently. 
This information is current as of [date] but may not reflect recent 
changes. Verify local regulations before purchasing or using CBD.
```

**Review Disclaimer (brand reviews):**
```
CBD Portal reviews brands using our published methodology. 
We do not accept payment for reviews or higher scores. 
We are independently owned and have no affiliate relationships.
```

### GDPR Compliance

- Cookie consent required
- Privacy policy published
- Data processing disclosed
- Unsubscribe available
- Data deletion process
- Newsletter consent explicit

---

## APPENDIX D: FUTURE MARKETS

### Rollout Sequence (After Phase 3)

| Phase | Market | Domain | Priority |
|-------|--------|--------|----------|
| 4 | UK | swissorganic.co.uk (migrate) or new | High |
| 5 | France | cbdportail.fr | High |
| 6 | Spain | cbdportal.es | Medium |
| 7 | Italy | CBD.it | Medium |
| 8 | Netherlands | cbdportaal.nl | Medium |
| 9 | Switzerland | cbdportal.ch | Medium |
| 10 | Nordic Bundle | CBD.se, CBD.no, CBD.fi | Medium |
| 11 | Portugal | CBD.pt | Lower |
| 12 | Romania | cbdportal.ro | Lower |

### Scaling Considerations

- Translation workflow automation
- Local brand research per market
- Local expert recruitment
- Market-specific legal monitoring
- Newsletter per market

---

## SUMMARY METRICS

| Metric | Value |
|--------|-------|
| **Total Knowledge Articles** | **850** |
| **Research Studies** | **698** |
| **Brand Reviews** | **100+ (EN) + local** |
| **Glossary Terms** | **251** |
| **Tools** | **7+** |
| **Total Ecosystem Pages** | **~1,900** |
| **Launch Markets** | **3 (EN, DA, DE)** |
| **Total Markets Planned** | **13** |
| **Domain Portfolio** | **13 domains** |
| **Production Timeline** | **12 weeks (EN)** |
| **Revenue Model** | **Newsletter sponsorship + ads** |

---

*Document Version: 5.0*  
*Created: January 10, 2026*  
*For: CBD Portal â€” Independent CBD Education Platform*
